Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1050.Time spend outdoors in summer,48529,0.0696379776149929,0.0313484890343849,0.00819493910759853,0.131081016122387,0.0263319639536394
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1060.Time spent outdoors in winter,44853,0.0267538055618108,0.0356245566563279,-0.0430703254845919,0.0965779366082134,0.452665069168352
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1070.Time spent watching television (TV),49675,0.147659341802138,0.031128042812237,0.0866483778901535,0.208670305714123,2.11063145264499e-06
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1080.Time spent using computer,44767,-0.128368825123,0.0334116317707575,-0.193855623393685,-0.0628820268523157,0.000122376395465288
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1090.Time spent driving,43677,0.00234712987902465,0.0350232454899589,-0.0662984312812947,0.070992691039344,0.946569367667462
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1160.Sleep duration,51446,-0.0358611641343031,0.0291183923151478,-0.0929332130719927,0.0212108848033865,0.218122489123453
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34321,-0.0105972178965486,0.0121992792717622,-0.0345078052692024,0.0133133694761053,0.385044445198308
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34321,0.00887088927264416,0.0120125710781944,-0.0146737500406168,0.0324155285859052,0.460247181542225
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34321,0.0103130907991817,0.0141273492914989,-0.0173765138121561,0.0380026954105195,0.465401087325321
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34321,-0.00496415454504349,0.0146146004816173,-0.0336087714890134,0.0236804623989264,0.734111195266723
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34321,0.0198128697095775,0.0150907397725035,-0.00976498024452935,0.0493907196636843,0.189240143913301
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34321,0.0202915166780202,0.0289796476558006,-0.0365085927273489,0.0770916260833892,0.483818685584366
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34321,-0.0533773602271786,0.0299502017558337,-0.112079755668613,0.00532503521425545,0.074745016614093
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34321,0.0248719746932628,0.0209453829793598,-0.0161809759462824,0.065924925332808,0.235069983678
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34321,0.00974340407607864,0.0155163206636987,-0.0206685844247709,0.0401553925769282,0.530053336170764
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34321,-0.00493391029796286,0.0108961575360443,-0.0262903790686097,0.0164225584726839,0.65069355146751
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34321,-0.00859026403862544,0.0154365022494058,-0.0388458084474609,0.02166528037021,0.577887615254184
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34321,-0.000184548962159089,0.00885428611969815,-0.0175389497567675,0.0171698518324493,0.983371376850563
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34321,-0.00377263986432134,0.0114012255444513,-0.0261190419314458,0.0185737622028031,0.740728350004722
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34321,0.0194194281343584,0.0172767277694363,-0.0144429582937367,0.0532818145624534,0.261029337003389
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34321,-0.00197533131972167,0.0163922798422162,-0.0341041998104654,0.0301535371710221,0.904086417302408
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34321,0.0353395016058488,0.0201636679580838,-0.00418128759199538,0.074860290803693,0.0796943861815636
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34321,-0.0134892582236997,0.0191219445724841,-0.0509682695857687,0.0239897531383692,0.480556276876289
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34321,-0.00852968627073312,0.0127110205617348,-0.0334432865717334,0.0163839140302671,0.50220570260683
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34321,-0.00368136374345437,0.0121269477842473,-0.0274501814005792,0.0200874539136704,0.761462414032587
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34321,0.0122983130856262,0.0148741611108017,-0.0168550426915452,0.0414516688627976,0.408355694897901
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120040.Fatigue severity over the past week,34329,0.116218990893283,0.0488383072406821,0.0204959087015461,0.21194207308502,0.0173460185836841
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34331,0.0978773805709682,0.0482637142579529,0.00328050062538063,0.192474260516556,0.042588548924213
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34329,0.0596275279892287,0.0532439192291809,-0.0447305536999659,0.163985609678423,0.262784773360861
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120098.Mobility problems today,34334,0.101893957699076,0.059712294186734,-0.0151421389069229,0.218930054305074,0.0879604819642633
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120099.Self-care problems today,34334,0.125992476784091,0.0928692653476581,-0.056031283297319,0.308016236865501,0.174916943035663
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120100.Problems doing usual activities,34334,0.130180385843542,0.0563854036523744,0.0196649946848883,0.240695777002196,0.0209762587888992
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120101.Pain or discomfort today,34334,0.0558781367792467,0.0487675173570361,-0.0397061972405442,0.151462470799038,0.251901423915375
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120102.Anxiety or depression today,34334,0.150438855522022,0.0578583076358377,0.0370365725557802,0.263841138488264,0.00933205731405158
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120103.Scale to indicate how health is today,34303,-0.0051195158000006,0.00384344357949615,-0.0126526652158131,0.00241363361581187,0.182885071882539
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34319,0.108922831460546,0.0581868803191625,-0.0051234539650129,0.222969116886104,0.0612416481906708
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34303,0.0710798196796823,0.0594030781424942,-0.0453502134796064,0.187509852838971,0.231502166762736
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34323,0.0252422968061243,0.0483348516454004,-0.0694940124188604,0.119978606031109,0.60151568140332
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34323,0.0938768953671453,0.0492820175280872,-0.00271585898790558,0.190469649722196,0.0568215753927889
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34320,0.0877308770584164,0.0605206372979872,-0.0308895720456385,0.206351326162471,0.147199338772093
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34296,0.105659131136245,0.0616215503084276,-0.0151191074682729,0.226437369740763,0.0864398852283349
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34326,0.0609171404376367,0.0620945582839123,-0.0607881937988314,0.182622474674105,0.326596531596459
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34311,0.214225010195275,0.0926790295005615,0.0325741123741747,0.395875908016376,0.0208261384607944
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34258,0.164352133354244,0.12082734690247,-0.0724694665745965,0.401173733283085,0.173788867253081
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31348,0.096912791709543,0.0647794239852109,-0.0300548793014704,0.223880462720556,0.134684653981535
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48433,0.135576751426786,0.0683084371096495,0.00169221469187253,0.269461288161699,0.0471808190931386
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47159,0.0238267890401099,0.0418849248322764,-0.0582676636311518,0.105921241711372,0.56945451826994
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1289.Cooked vegetable intake,50447,-0.143827803083836,0.0300962519420612,-0.202816456890276,-0.0848391492773966,1.77173618733135e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49919,-0.21230638943756,0.0323257734999992,-0.275664905497558,-0.148947873377562,5.20558808106662e-11
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1309.Fresh fruit intake,50427,-0.294417620838876,0.0321312742998879,-0.357394918466657,-0.231440323211096,5.40326645969529e-20
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1319.Dried fruit intake,48894,-0.268881555324201,0.034042430940322,-0.335604719967232,-0.20215839068117,2.93990313401557e-15
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X134.Number of self-reported cancers,51670,0.172133511632946,0.0671134494645799,0.0405911506823691,0.303675872583522,0.0103283133467358
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51670,0.132322488214108,0.0294201835183912,0.0746589285180618,0.189986047910155,6.89776113285244e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X136.Number of operations, self-reported",51670,0.04406608096068,0.0292755678274555,-0.0133140319811328,0.101446193902493,0.132279665743725
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X137.Number of treatments or medications taken,51670,0.111117311143638,0.0292241640940623,0.0538379495192754,0.168396672768,0.000143699319188075
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1438.Bread intake,50804,0.00302015013802721,0.00243984221696773,-0.00176194060722954,0.00780224088328397,0.215783770539201
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1458.Cereal intake,50054,-0.191420408374786,0.0303458322588257,-0.250898239602084,-0.131942577147487,2.87246732852722e-10
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1488.Tea intake,50589,-0.00489638146171785,0.0023001700099632,-0.00940471468124573,-0.00038804824218998,0.0332878623562648
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1498.Coffee intake,49360,-0.0407804240497215,0.0303716346166573,-0.10030882789837,0.0187479797989268,0.179376498105421
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1528.Water intake,49693,-0.160708527631295,0.0312392684049777,-0.221937493705051,-0.0994795615575383,2.7028073395572e-07
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1568.Average weekly red wine intake,42745,-0.173476854140561,0.0357560695046991,-0.243558750369771,-0.10339495791135,1.23398847897592e-06
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42737,0.0165116220035864,0.0366784502452783,-0.0553781404771592,0.088401384484332,0.652591383653744
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,42782,0.0822863483501608,0.0400847644291036,0.00372021006911773,0.160852486631204,0.0401048677730729
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1598.Average weekly spirits intake,42704,0.0598809729668937,0.0401972755167134,-0.0189056870458647,0.138667632979652,0.136325816166982
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1608.Average weekly fortified wine intake,42774,-0.0557964228537746,0.0729977349435268,-0.198871983343087,0.087279137635538,0.444663301810712
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1737.Childhood sunburn occasions,45233,-0.118140002508913,0.0356521816328843,-0.188018278509366,-0.0482617265084593,0.000922290559438263
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1807.Father's age at death,40455,-0.00132819195444764,0.00325469314348979,-0.00770739051568763,0.00505100660679235,0.683216423456167
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1845.Mother's age,39710,-0.00582837413729585,0.00495415027715564,-0.0155385086805209,0.00388176040592921,0.23942760673081
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1873.Number of full brothers,51171,0.0302336225102117,0.0294142127117555,-0.027418234404829,0.0878854794252523,0.304025913288402
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1883.Number of full sisters,51172,0.012565332794776,0.0293849322018219,-0.0450291343207949,0.0701597999103468,0.668937416440326
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20015.Sitting height,51442,-0.0203482628081737,0.00308151795940711,-0.0263880380086117,-0.0143084876077358,4.09339441182877e-11
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20016.Fluid intelligence score,32612,-0.0749155946125417,0.0486675966792229,-0.170304084103819,0.0204728948787352,0.123759438340009
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20018.Prospective memory result,32936,0.0617397389658679,0.0686752000679262,-0.0728636531672675,0.196343131099003,0.368670819517019
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32524,0.00113652891794956,0.0043632202541803,-0.00741538278024383,0.00968844061614295,0.794500207068979
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32516,0.000856076668531461,0.00434569736027749,-0.00766149015761242,0.00937364349467534,0.843836792833639
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20023.Mean time to correctly identify matches,51361,0.00582431240588617,0.00244460916359627,0.00103287844523748,0.0106157463665349,0.017201691836059
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48451,0.00704710887305678,0.00530797266963516,-0.00335651755942814,0.0174507353055417,0.18430739276142
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48023,0.0143106141333886,0.0120469409203449,-0.00930139007048742,0.0379226183372646,0.234882752032941
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47989,0.00812320293144256,0.0160749769524921,-0.0233837518954421,0.0396301577583272,0.613330169417685
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48019,0.0189276595294571,0.0123975222273892,-0.00537148403622573,0.04322680309514,0.126841447523545
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48023,0.00398266541054963,0.00905699850770938,-0.0137690516645608,0.02173438248566,0.660134088732414
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#2.Illnesses of father_Stroke,48181,0.0141345766103002,0.00697751969860603,0.000458638001032383,0.027810515219568,0.0428032743115614
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48119,-0.000646795126373189,0.00906121435805767,-0.0184067752681662,0.0171131850154198,0.943095419259098
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48027,0.0117544489128891,0.0109537620389005,-0.00971492468335596,0.0332238225091341,0.283238322822973
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48149,0.0116869509780464,0.00863477137640455,-0.00523720091970649,0.0286111028757993,0.175916386500693
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48303,0.0118575733066175,0.0054840593463192,0.00110881698783185,0.0226063296254031,0.030613273944734
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48153,0.0279584156755723,0.00747917720218708,0.0132992283592856,0.042617602991859,0.00018579153026928
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49502,-0.00451964467202113,0.00634626619555077,-0.0169583264153007,0.00791903707125838,0.476363622831486
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49375,0.0108311710644353,0.0102839120838955,-0.00932529661999982,0.0309876387488705,0.292252412211221
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49319,-0.0407056624014672,0.0217077257322371,-0.0832528048366519,0.00184148003371759,0.0607808635585118
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49365,0.00248635367196972,0.00926317090764213,-0.0156694613070089,0.0206421686509483,0.788383756105654
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49446,-0.000525873071248524,0.00752398912048378,-0.0152728917473967,0.0142211456048997,0.944279487314054
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49372,0.011581280460883,0.0122595671397164,-0.0124474711329611,0.0356100320547272,0.344834858744055
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49348,0.0197093802173476,0.0116352619546855,-0.00309573321383599,0.0425144936485312,0.0902898081757891
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49384,-0.00481238327040899,0.00880963432815782,-0.0220792665535983,0.0124545000127803,0.584889472962613
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49387,0.00591612130699034,0.0103134260597974,-0.0142981937702125,0.0261304363841932,0.566221244104147
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49599,0.00601383985433809,0.00499938268335889,-0.00378495020504534,0.0158126299137215,0.229019704352296
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49438,0.0191266703809018,0.0077464301577675,0.00394366727167754,0.0343096734901261,0.0135520164783897
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46673,-0.0011938399001942,0.0101759488884114,-0.0211386997214806,0.0187510199210922,0.906607698273671
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46561,0.0349766114183525,0.0564073258028194,-0.0755817471551735,0.145534969991879,0.535216515095399
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46560,-0.0303620002178622,0.0482489799394323,-0.12493000089915,0.0642060004634251,0.529173694390337
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46648,-0.00642604407451561,0.00930881577643082,-0.02467132299632,0.0118192348472888,0.49000119469003
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46566,0.0498135656425588,0.0311439807359478,-0.0112286365998988,0.110855767885016,0.109732241541565
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46580,0.00744056889123795,0.0176279731133723,-0.0271102584109717,0.0419913961934476,0.672964243091212
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46568,0.024397071939584,0.0236136460730387,-0.0218856743635719,0.0706798182427398,0.301532157933619
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46576,0.0228646934992175,0.0209581688931863,-0.0182133175314275,0.0639427045298626,0.275298495181154
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46581,0.00465854539735935,0.0140161911705499,-0.0228131892969184,0.0321302800916371,0.739613820014525
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46585,0.0462887209295652,0.0184863534309903,0.0100554682048241,0.0825219736543062,0.0122888359777404
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46768,0.00145721674023193,0.0065493762077424,-0.0113795606269432,0.014293994107407,0.823928970331411
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46660,0.0211609820511909,0.00958555161998182,0.00237330087602658,0.0399486632263553,0.0272826840630957
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20127.Neuroticism score,46197,0.104217072721229,0.0306703479480786,0.0441031907429944,0.164330954699463,0.000680051698969529
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32612,0.029846120100142,0.0494213674864219,-0.0670197601732449,0.126712000373529,0.54591831716502
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20161.Pack years of smoking,31520,0.0205382067240969,0.00504528706370413,0.0106494440792368,0.030426969368957,4.7329168725907e-05
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31520,0.0188194829745994,0.00471810352233038,0.00957200007083187,0.028066965878367,6.70318934335772e-05
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20191.Fluid intelligence score,31252,-0.0631441551094557,0.0540025225532275,-0.168989099313782,0.0427007890948701,0.242327964392088
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31252,0.00443276341449244,0.0550933792784492,-0.103550259971268,0.112415786800253,0.935874310173183
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20240.Maximum digits remembered correctly,30617,-0.0660668375017809,0.056789011006601,-0.177373299074719,0.045239624071157,0.244719075613478
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20255.Spirometry QC measure,44670,0.0828665042477996,0.039663798153568,0.00512545986680622,0.160607548628793,0.0366998028313969
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20261.avMSE,29838,-0.00499221344893172,0.00546885166493908,-0.0157111627122123,0.00572673581434888,0.361360922514117
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20262.Myopia diagnosis,29838,0.0179259164701337,0.0708900743210534,-0.121018629199131,0.156870462139398,0.800377985931318
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20280.Glucose-lactate,39545,0.0200254217525279,0.00315757439555863,0.013836575937233,0.0262142675678228,2.3296960890132e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39581,0.0172373995510881,0.00312225828194561,0.0111177733184747,0.0233570257837015,3.42780517102203e-08
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32518,-0.000385625085213392,0.0148820755510405,-0.0295544931652527,0.0287832429948259,0.979328085972779
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32515,0.052131756458004,0.0297123427920386,-0.00610443541439175,0.1103679483304,0.0793718929432689
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32513,0.011164327765211,0.0331413311101726,-0.0537926812107272,0.0761213367411493,0.7362228993163
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32513,0.00337725140091868,0.0143561329384233,-0.0247607691583911,0.0315152719602284,0.814021828067252
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32513,-0.00472778482179253,0.023187444158986,-0.0501751753734051,0.04071960572982,0.838440991150112
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32521,-0.026627712651182,0.0300923364493605,-0.0856086920919286,0.0323532667895647,0.376252983070736
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32521,-0.00155247681291678,0.019648872925908,-0.0400642677476964,0.0369593141218628,0.937025710579883
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32521,0.000877478806558619,0.0214050762899709,-0.0410764707217844,0.0428314283349017,0.967301657238087
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32521,-0.0137048944908184,0.0332254984407597,-0.0788268714347074,0.0514170824530707,0.679996944429895
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32521,-0.0270175746457655,0.0382273464216394,-0.101943173632179,0.0479080243406476,0.479734400735772
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32521,-0.000630416694943023,0.0220722058387615,-0.0438919401389155,0.0426311067490294,0.977214926006399
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32521,-0.0212722100534213,0.0376821664744951,-0.0951292563434317,0.052584836236589,0.572417197085242
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32521,-0.0257517795657109,0.0286659743792765,-0.0819370893490928,0.0304335302176711,0.369029506496178
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32523,-0.0182927028003793,0.0389739285262054,-0.0946816027117419,0.0580961971109834,0.638825986151151
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32523,0.00694175801264698,0.0192021747652103,-0.0306945045271652,0.0445780205524592,0.717727832902165
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32523,0.00385885393258803,0.0263633013754086,-0.0478132167632128,0.0555309246283889,0.883630992543579
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32523,0.0415414492579339,0.043783458264227,-0.0442741289399509,0.127357027455819,0.342752246703543
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20600.Liking for adding salt to foods,35202,0.011227267656286,0.043780267944505,-0.0745820575149439,0.0970365928275159,0.797611249392849
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20601.Liking for aniseed,35202,-0.0135502461832432,0.0435314236458521,-0.0988718365291133,0.0717713441626268,0.755597256352123
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20602.Liking for apple juice,35202,0.0611440072631296,0.0439686344812055,-0.0250345163200332,0.147322530846292,0.164365614336518
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20603.Liking for apples,35202,0.00312019622520977,0.044591016058766,-0.0842781952499715,0.090518587700391,0.944215865733166
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20604.Liking for asparagus,35202,-0.172797260736178,0.0445612902241229,-0.260137389575459,-0.0854571318968967,0.000106025191485725
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20605.Liking for aubergine,35202,-0.191688949500543,0.0438894190068732,-0.277712210754014,-0.105665688247071,1.26767842750218e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20606.Liking for avocados,35202,-0.147169040519885,0.0443033732998299,-0.234003652187551,-0.0603344288522179,0.000897065092654935
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20607.Liking for bacon,35202,0.0891843352488483,0.0442536924353362,0.00244709807558939,0.175921572422107,0.0438970986914531
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20608.Liking for baked or steamed fish,35202,-0.139067170156798,0.0446472800650037,-0.226575839084206,-0.051558501229391,0.00184531329810341
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20609.Liking for bananas,35202,-0.0355469833185823,0.0452777876642516,-0.124291447140515,0.0531974805033509,0.43241922065067
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35202,-0.00239948988590352,0.043979400343554,-0.0885991145592694,0.0838001347874623,0.956490442913633
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20611.Liking for beef steak,35202,0.0825132783144612,0.0441516218291452,-0.00402390047066334,0.169050457099586,0.0616678230278149
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20612.Liking for beetroot,35202,-0.0443941910064041,0.0446536259456691,-0.131915297859916,0.0431269158471074,0.320151573096645
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20613.Liking for bell pepper,35202,-0.114013798794139,0.0442442900449241,-0.20073260728219,-0.0272949903060876,0.00998115899187459
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20614.Liking for bicycling,35202,-0.191326757355165,0.0441333153240646,-0.277828055390331,-0.104825459319998,1.46884768485659e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20615.Liking for biscuits,35202,0.0960409854242465,0.0439241556138564,0.00994964042108805,0.182132330427405,0.0287980600993933
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20616.Liking for bitter foods,35202,-0.129384984592388,0.0437602064627204,-0.21515498925932,-0.0436149799254557,0.0031161044335173
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20617.Liking for bitter or ale,35202,-0.0206751018031662,0.0449367596409258,-0.108751150699381,0.0674009470930485,0.645458083405166
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20618.Liking for black olives,35202,-0.154859698656696,0.044199142979368,-0.241490018896257,-0.0682293784171345,0.000460644756706326
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20619.Liking for black pepper,35202,0.00377336750895511,0.0441925864363511,-0.0828441019062931,0.0903908369242033,0.931957122684809
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20620.Liking for blue cheese,35202,-0.0560307230904634,0.0438287843697305,-0.141935140455135,0.0298736942742084,0.201134562827995
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20621.Liking for bolognese sauce,35202,0.0573800058175619,0.0441854539902643,-0.0292234840033563,0.14398349563848,0.194101636373716
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20622.Liking for broad beans,35202,-0.0688258137362051,0.0436117359931218,-0.154304816282724,0.0166531888103137,0.114559313211745
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20623.Liking for broccoli,35202,-0.062927695493265,0.0452092743244417,-0.151537873169171,0.0256824821826407,0.163973923710001
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20624.Liking for brown rice,35202,-0.158840244361449,0.043875094085813,-0.244835428769642,-0.0728450599532555,0.000295564480567604
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20625.Liking for brussel sprouts,35202,-0.0669669254872048,0.0441825994670838,-0.153564820442689,0.0196309694682795,0.12962678476762
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20626.Liking for burgers (meat),35202,0.0687164476427875,0.0437966582396398,-0.0171250025069064,0.154557897792481,0.116678565810546
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20627.Liking for burn of spicy foods,35202,-0.0526204326120846,0.0438018899728072,-0.138472136958787,0.0332312717346175,0.229649135856929
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20628.Liking for butter on bread,35202,0.0979572356697886,0.0443885272728486,0.0109557222150053,0.184958749124572,0.0273470114930451
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20629.Liking for butternut squash,35202,-0.136399869578347,0.0439318032387204,-0.222506203926238,-0.0502935352304546,0.00190871159037476
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20630.Liking for cabbage,35202,-0.0285196314019495,0.0444066128460428,-0.115556592580193,0.0585173297762943,0.520731403069461
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20631.Liking for cake,35202,0.0454945201662551,0.0442024844910191,-0.0411423494361424,0.132131389768653,0.303393604532961
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20632.Liking for cake icing,35202,0.0373902965430066,0.0435003357117323,-0.0478703614519888,0.122650954538002,0.390060614307501
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20633.Liking for capers,35202,-0.134162225724359,0.0435536779611811,-0.219527434528274,-0.048797016920444,0.00207226203756193
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20634.Liking for cauliflower,35202,-0.0346210656362448,0.0445991048177191,-0.122035311078974,0.0527931798064846,0.437604213456317
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20635.Liking for cereal or granola bar,35202,-0.00474016463917619,0.0438849706497398,-0.0907547071126661,0.0812743778343137,0.913986979355556
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20636.Liking for cheesecake,35202,0.0359449573290729,0.043954073606883,-0.0502050269404178,0.122094941598564,0.413497478857015
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20637.Liking for cherries,35202,-0.108250217001307,0.0457390693213975,-0.197898792871246,-0.0186016411313683,0.0179646528553694
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20638.Liking for chicken,35202,-0.0257712504834788,0.0459143707057236,-0.115763417066697,0.0642209160997395,0.574611351183086
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20639.Liking for chilli pepper,35202,-0.0547025413138409,0.0435415965881531,-0.140044070626621,0.0306389879989392,0.209022850849928
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20640.Liking for chips or french fries,35202,0.114288687113346,0.0443028226385592,0.0274551547417697,0.201122219484922,0.00990064395062845
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20641.Liking for cigarette smoking,35202,-0.0600076419078033,0.0688091976375926,-0.194873669277485,0.0748583854618783,0.383179113722207
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20642.Liking for cod,35202,-0.0502716541396952,0.0454255100976305,-0.139305653931051,0.0387623456516606,0.268454361022272
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20643.Liking for coffee with sugar,35202,0.112960107095299,0.0483000831958487,0.0182919440314354,0.207628270159162,0.0193674999115753
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20644.Liking for coffee without sugar,35202,-0.12787636561276,0.0447088578329663,-0.215505726965374,-0.0402470042601457,0.00424144920990991
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20645.Liking for coriander,35202,-0.121696865978575,0.0437477215028432,-0.207442400124148,-0.0359513318330025,0.00541497708416506
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20646.Liking for corn flakes,35202,0.199485474211703,0.0440360929885262,0.113174731954192,0.285796216469214,5.95738195051979e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20647.Liking for cream,35202,0.131530113616136,0.0437081157709563,0.045862206705062,0.217198020527211,0.00262440343324348
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20648.Liking for croissant,35202,0.0693194447586228,0.0439218298558982,-0.0167673417589378,0.155406231276183,0.114537055130064
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20649.Liking for cucumber,35202,0.0234435063179367,0.0441039848449494,-0.0630003039781641,0.109887316614038,0.595047599708075
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20650.Liking for curry,35202,-0.0210793524414993,0.0444153768790546,-0.108133491124446,0.0659747862414478,0.635084227074186
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20651.Liking for dairy products,35202,0.0773020022181116,0.0443942068918691,-0.00971064328995182,0.164314647726175,0.0816645749723165
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20652.Liking for dark chocolate,35202,-0.108484985688747,0.0442100830246663,-0.195136748417092,-0.0218332229604008,0.0141484674535544
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35202,0.091640212623591,0.0449066509041259,0.00362317685150422,0.179657248395678,0.0413055289945803
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20654.Liking for dried fruit,35202,-0.13905015068891,0.0440665799631532,-0.22542064741669,-0.0526796539611298,0.00160666747907713
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20655.Liking for eggs,35202,-0.0315934131947134,0.0453762300138968,-0.120530824021951,0.0573439976325244,0.486283618763049
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20656.Liking for exercising alone,35202,-0.0945306440403276,0.0437375264078997,-0.180256195799811,-0.00880509228084425,0.0306917620313843
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20657.Liking for exercising with others,35202,-0.227103156841272,0.0440342858022817,-0.313410357013744,-0.1407959566688,2.54606445788216e-07
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35202,-0.077869722182002,0.0444028301371747,-0.164899269250864,0.00915982488686048,0.0795071057966734
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20659.Liking for fatty foods,35202,0.0600744607307362,0.043500157633842,-0.0251858482315941,0.145334769693066,0.167300939227985
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20660.Liking for fresh tomatoes,35202,-0.070782558055026,0.0472147175956139,-0.163323404542429,0.0217582884323772,0.133859203066748
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20661.Liking for fried chicken,35202,0.126081711729069,0.0439148642163076,0.0400085778651059,0.212154845593032,0.00409870533295886
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20662.Liking for fried or battered fish,35202,0.0382365139838507,0.0444031432330452,-0.0487936467529178,0.125266674720619,0.389189189709665
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20663.Liking for fruit,35202,-0.0680108323293701,0.0478625851335517,-0.161821499191131,0.0257998345323913,0.155355820466643
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20664.Liking for garlic,35202,-0.0613542856756348,0.0444109709278166,-0.148399788694155,0.0256912173428859,0.167148850059666
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20665.Liking for gherkins,35202,-0.110898367459836,0.0436860101728852,-0.196522947398691,-0.0252737875209811,0.0111451033809691
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20666.Liking for globe artichoke,35202,-0.104803636586039,0.0441346848373015,-0.19130761886715,-0.0182996543049282,0.0175830033029028
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20667.Liking for goat's cheese,35202,-0.16809055026889,0.0437495594789099,-0.253839686847554,-0.0823414136902271,0.000122647272052048
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20668.Liking for going to a cafe,35202,0.00789817064818077,0.0442975148951187,-0.0789249585462519,0.0947212998426134,0.858491917581356
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20669.Liking for going to the gym,35202,-0.198477784418915,0.0437532295994759,-0.284234114433887,-0.112721454403942,5.78378326640809e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20670.Liking for going to the pub,35202,-0.0817563682372848,0.0437685334677289,-0.167542693834033,0.00402995735946385,0.0617982163769968
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20671.Liking for grapefruit,35202,-0.0929900468408294,0.0435564288351812,-0.178360647357785,-0.00761944632387433,0.0327878885086917
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20672.Liking for green olives,35202,-0.132233373714338,0.0441761662433519,-0.218818659551308,-0.0456480878773686,0.0027655587845786
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20673.Liking for haddock,35202,-0.128556811260035,0.0448758509515034,-0.216513479124982,-0.0406001433950885,0.00418143382341134
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20674.Liking for ham,35202,0.126622081514298,0.0440090380162169,0.0403643670025126,0.212879796026083,0.00401991267099182
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20675.Liking for hard cheese,35202,-0.0124470367566881,0.0449935879797675,-0.100634469197032,0.0757403956836562,0.78206141167974
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20676.Liking for herring,35202,-0.162366083275876,0.0438015799786302,-0.248217180033991,-0.0765149865177608,0.000210849393553534
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20677.Liking for honey,35202,-0.0156275086736127,0.0434531039920496,-0.10079559249803,0.0695405751508044,0.719122476312229
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35202,-0.0842497574756929,0.0437281376312393,-0.169956907232922,0.00145739228153623,0.054045553868213
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20679.Liking for ice cream,35202,0.0779623460847842,0.0444430892913178,-0.00914610892619871,0.165070801095767,0.0794221937261176
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20680.Liking for jam,35202,0.0641975087004674,0.0436643737011856,-0.0213846637538564,0.149779681154791,0.141522046263974
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20681.Liking for kiwi fruit,35202,-0.0737077746015583,0.0437202720063445,-0.159399507733994,0.0119839585308769,0.0918436113800309
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20682.Liking for lager,35202,-0.0286910127892304,0.0439899600600951,-0.114911334507017,0.0575293089285561,0.514274231559564
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20683.Liking for lamb,35202,0.00484526352261618,0.0440512127762153,-0.0814951135187658,0.0911856405639981,0.912417981604348
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20684.Liking for lemons,35202,-0.101060800110108,0.043998215417005,-0.187297302327438,-0.0148242978927783,0.021640935789911
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20685.Liking for lentils or beans,35202,-0.0958926639650044,0.0442519000325981,-0.182626388028897,-0.00915893990111223,0.0302576914174938
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20686.Liking for liver,35202,-0.0904193292330369,0.0439269344377939,-0.176516120731113,-0.00432253773496098,0.0395742831179414
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20687.Liking for mackerel,35202,-0.164878549610368,0.0438831440216447,-0.250889511892792,-0.0788675873279443,0.000172674019899272
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20688.Liking for marzipan,35202,-0.0717519510863642,0.043517651798441,-0.157046548611309,0.0135426464385801,0.0992161117159635
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20689.Liking for mayonnaise,35202,0.0569513226127772,0.0441950382515839,-0.0296709523603273,0.143573597585882,0.197550925237076
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20690.Liking for melon,35202,0.00603394334730211,0.0451647363964359,-0.0824889399897122,0.0945568266843164,0.893722402039668
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20691.Liking for milk chocolate,35202,0.0878515379852734,0.0440573678641472,0.00149909697154496,0.174203978999002,0.0461731312070335
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20692.Liking for mushrooms,35202,-0.0637843854004502,0.0454117081507383,-0.152791333375897,0.025222562574997,0.160173558577715
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20694.Liking for orange juice,35202,0.109847828394325,0.043952433034417,0.0237010596468678,0.195994597141782,0.0124599139827392
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20695.Liking for oranges,35202,-0.047502717319884,0.0447906623545176,-0.135292415534738,0.0402869808949705,0.28891725603035
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20696.Liking for pasta,35202,0.0340017802151932,0.0443296285513921,-0.0528842917455353,0.120887852175922,0.443084683351772
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20697.Liking for pears,35202,-0.0140013575885148,0.0445913921393609,-0.101400486181662,0.0733977710046327,0.753532601368942
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20698.Liking for pizza,35202,0.0974342122655482,0.0439737160833307,0.0112457287422201,0.183622695788876,0.026729279624378
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20699.Liking for plain yogurt,35202,-0.0884229623401457,0.0440286168370513,-0.174719051340766,-0.00212687333952509,0.0446344015935345
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20700.Liking for plums,35202,-0.103602406872214,0.0448968287938331,-0.191600191308127,-0.0156046224363012,0.0210412008929481
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20701.Liking for pollock,35202,-0.169803789128038,0.0436941773512939,-0.255444376736575,-0.0841632015195024,0.000102410541834043
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20702.Liking for pork chop,35202,-0.00132048696957362,0.0439044524642231,-0.087373213799451,0.0847322398603038,0.976006668322076
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20703.Liking for porridge,35202,-0.0505827782739374,0.0446006190624499,-0.137999991636339,0.0368344350884644,0.25676515544097
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20704.Liking for potato crisps,35202,0.0583804051440005,0.0442397807475554,-0.0283295651212081,0.145090375409209,0.186983250557804
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20705.Liking for potatoes,35202,0.164644250637836,0.0445996938297914,0.077228850731445,0.252059650544227,0.000223892798642023
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20706.Liking for prawns,35202,-0.118561069703417,0.0446005890018043,-0.205978224146953,-0.0311439152598807,0.00786497591684477
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20707.Liking for raw carrots,35202,-0.106852124983353,0.0443243711376689,-0.193727892413184,-0.0199763575535222,0.0159383804262357
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20708.Liking for red meat,35202,0.0971014944625442,0.043936762223719,0.0109854405040549,0.183217548421033,0.0271230978196727
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20709.Liking for red wine,35202,-0.102037547139662,0.0442129605304164,-0.188694949779278,-0.0153801445000461,0.0210245638238752
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35202,0.134606202746976,0.0452507241762746,0.0459147833614778,0.223297622132474,0.00293917199352535
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20711.Liking for roast chicken,35202,0.0265767596799218,0.0460539561562581,-0.063688994386344,0.116842513746188,0.563897717969512
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20712.Liking for salad dressing,35202,0.0567549982122638,0.0439891874028249,-0.0294638090972729,0.142973805521801,0.197006377296346
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20713.Liking for salad leaves,35202,-0.0607328129160782,0.0449552698771006,-0.148845141875195,0.0273795160430391,0.176734920869656
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20714.Liking for salami,35202,-0.0296186628091837,0.0438780929633514,-0.115619725017353,0.0563823993989851,0.499675779458619
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20715.Liking for salmon,35202,-0.131598636092624,0.0456220893649734,-0.221017931247972,-0.0421793409372764,0.00392727545994672
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20716.Liking for salty foods,35202,0.0214392583338714,0.0438565022993464,-0.0645194861728475,0.10739800284059,0.624957240081151
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20717.Liking for salty pretzels,35202,-0.0186161113432691,0.0438711928484115,-0.104603649326156,0.0673714266396175,0.671329094541319
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20718.Liking for sardines,35202,-0.230111136116034,0.0441177039318941,-0.316581835822547,-0.143640436409522,1.86207497653138e-07
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20719.Liking for sausages (meat),35202,0.0963043576146124,0.0438200296337972,0.0104170995323699,0.182191615696855,0.027988892236266
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20720.Liking for savoury biscuits,35202,0.0788891248997533,0.0439835228783239,-0.00731857994176145,0.165096829741268,0.0729026764280915
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35202,-0.129767297306671,0.0439313794144568,-0.215872800959006,-0.0436617936543356,0.00314467538663022
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20722.Liking for skimmed milk,35202,-0.0804240301255567,0.0437325321195389,-0.166139793079853,0.00529173282873958,0.0659416568935164
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20723.Liking for smoked fish,35202,-0.153465936756994,0.044064153916643,-0.239831678433614,-0.0671001950803735,0.000498100216644905
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20724.Liking for soft cheese,35202,-0.00200701507640826,0.0438496659341993,-0.0879523603074388,0.0839383301546223,0.963494088302342
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20725.Liking for soy sauce,35202,0.0140358944127433,0.0440663117965197,-0.0723340767084353,0.100405865533922,0.750098241051654
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20726.Liking for soya milk,35202,-0.0965541049276602,0.0439894396790602,-0.182773406698618,-0.0103348031567022,0.0281882367757935
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20727.Liking for spicy foods,35202,-0.0483765483150496,0.0441138501119466,-0.134839694534465,0.0380865979043657,0.272826698274807
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20728.Liking for spinach,35202,-0.168232937400235,0.0443058938553812,-0.255072489356782,-0.0813933854436879,0.000147175521003167
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20729.Liking for spirits,35202,-0.00837221173747854,0.0437874700151882,-0.0941956529672474,0.0774512294922903,0.848371479404959
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20730.Liking for strawberries,35202,-0.00744279825174404,0.0477703793566133,-0.101072741790706,0.0861871452872181,0.876190588447583
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35202,0.163302244920366,0.0449551520373485,0.0751901469271629,0.251414342913569,0.00028186358493593
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20732.Liking for sweet foods,35202,0.0717358156336565,0.0439330668544663,-0.0143729954010974,0.15784462666841,0.102529729436692
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20733.Liking for taking the stairs,35202,-0.115041707324666,0.0448253286395016,-0.202899351458089,-0.027184063191243,0.010287441652451
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20734.Liking for tea with sugar,35202,0.189972884350347,0.0529685415204242,0.0861545429703155,0.293791225730378,0.00033652752334715
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20735.Liking for tea without sugar,35202,-0.218513440892344,0.0462720532890933,-0.309206665338967,-0.127820216445721,2.35916046497838e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20736.Liking for tomato ketchup,35202,0.0488267391018428,0.0438410361762192,-0.0371016918035468,0.134755170007232,0.265421964695137
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20737.Liking for tinned tuna,35202,-0.0888193201325265,0.0443260018156822,-0.175698283691264,-0.0019403565737894,0.0451179603817219
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20738.Liking for turnip (white),35202,-0.112485681964784,0.0437955181128566,-0.198324897465983,-0.0266464664635851,0.010228751624671
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20739.Liking for vegetables,35202,-0.104513400697893,0.0483430590063273,-0.199265796350294,-0.009761005045491,0.0306458843074106
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20740.Liking for vinegar,35202,0.00112943686580445,0.04407130935817,-0.0852503294762087,0.0875092032078176,0.979554913778732
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20741.Liking for watching television,35202,0.0843751296035405,0.0444590006564461,-0.00276451168309387,0.171514770890175,0.057745336206748
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20742.Liking for whisky,35202,-0.0339400694288735,0.045727567545664,-0.123566101818375,0.055685962960628,0.457967391728035
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20743.Liking for white bread,35202,0.126747080843863,0.0435481957239151,0.0413926172249894,0.212101544462736,0.00361551966767494
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20744.Liking for white rice,35202,0.0745637125057983,0.044144016495826,-0.0119585598260207,0.161085984837617,0.0912275405091264
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20745.Liking for white wine,35202,-0.0564724772840056,0.0440512518065908,-0.142812930824924,0.0298679762569123,0.199878645955478
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35202,-0.0945354456809576,0.0441220902653699,-0.181014742601083,-0.00805614876083263,0.0321674619468864
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20747.Liking for whole milk,35202,0.133173683652356,0.0437591962020972,0.0474056590962456,0.218941708208467,0.00234511471450377
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20748.Liking for wholemeal bread,35202,-0.0675775690900891,0.0454808807094129,-0.156720095280538,0.0215649571003603,0.137347766410378
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20749.Liking for working up a sweat,35202,-0.208277463296785,0.0440368830141405,-0.294589754004501,-0.12196517258907,2.27661128802143e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21001.Body mass index (BMI),51541,0.0216312045308732,0.00976266358484032,0.00249638390458619,0.0407660251571603,0.0267196620175541
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21002.Weight,51561,-0.0338615030798359,0.00565957904226052,-0.0449542780026665,-0.0227687281570053,2.21694037025688e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32853,0.0290154571596031,0.00454632725149145,0.0201046557466798,0.0379262585725263,1.83214986644741e-10
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34566,0.11688018219613,0.0465864293555901,0.0255707806591734,0.208189583733087,0.0121258141402512
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34566,-0.0322010508437725,0.0488568579442959,-0.127960492414593,0.0635583907270474,0.509852361831561
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34566,-0.068249188964531,0.0480039349111728,-0.16233690139043,0.0258385234613677,0.155130430227446
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21040.Satisfaction with bowel habits,34536,0.0248457576563934,0.0445683379196613,-0.0625081846661428,0.11219969997893,0.577214273283421
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34535,0.0486713434208527,0.0472405085295501,-0.0439200532970655,0.141262740138771,0.302898049675647
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34525,0.0392461743173807,0.0482725930058817,-0.0553681079741475,0.133860456608909,0.416229602344114
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21043.Least number of times bowels opened per week,34469,0.0426016810349768,0.0476089802987482,-0.0507119203505697,0.135915282420523,0.370901224436987
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21044.Average number of times bowels opened per day,34499,0.110089038162354,0.0535684525908958,0.00509487108419858,0.21508320524051,0.0398928039710873
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34571,-0.0298179861142151,0.048510086547448,-0.124897755747213,0.0652617835187831,0.538781768557768
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34566,-0.00170176335780972,0.0488226785571447,-0.0973942133298134,0.0939906866141939,0.972195214853703
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30120,0.102226207089896,0.0723319956610488,-0.03954450440576,0.243996918585551,0.157619710195271
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34568,-0.0768756655044239,0.0513606081046679,-0.177542457389573,0.0237911263807251,0.134479306318487
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34566,-0.145888821526653,0.0730883556639,-0.289141998627897,-0.00263564442540876,0.045952563733464
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34569,-0.0158839384535124,0.058109570082041,-0.129778695814313,0.098010818907288,0.784593589315627
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34568,-0.121134862830679,0.1422663091752,-0.399976828814071,0.157707103152713,0.394529828577742
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34569,-0.0327293451528022,0.0548814269430291,-0.140296941961139,0.0748382516555349,0.550944230471631
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34570,-0.257648999640874,0.0572194639099504,-0.369799148904377,-0.145498850377371,6.77661377892546e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34323,0.0416676549446233,0.0508941644663548,-0.0580849074094321,0.141420217298679,0.412969490424808
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34569,-0.0731531455389897,0.0504702740291622,-0.172074882636148,0.0257685915581682,0.147246731013136
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34571,-0.0797720409404849,0.0695306328040135,-0.216052081236351,0.0565079993553816,0.251285980393585
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34568,-0.153361777057429,0.0484800814824823,-0.248382736763095,-0.0583408173517639,0.00156375045544508
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34566,-0.057424610433262,0.0486278460238603,-0.152735188640028,0.0378859677735042,0.23766879304603
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X21100.Water hardness (USGS classification),51311,0.000406279522735895,0.0298704369427138,-0.0581397768849831,0.0589523359304548,0.989148092750292
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2139.Age first had sexual intercourse,48639,-0.00181495766203086,0.00260144416833458,-0.00691378823196664,0.00328387290790491,0.485388190036236
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2149.Lifetime number of sexual partners,46664,-0.0781692820947398,0.0337103009350642,-0.144241471927466,-0.012097092262014,0.0204117225660265
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22032.IPAQ activity group,46648,-0.178334277505339,0.0324207242048949,-0.241878896946933,-0.114789658063745,3.82512465800466e-08
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22033.Summed days activity,47217,-0.0142701256323609,0.00250841217222937,-0.0191866134899304,-0.00935363777479129,1.29382976150773e-08
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22034.Summed minutes activity,46648,-0.00723724852213116,0.00256023627157428,-0.0122553116144167,-0.00221918542984558,0.0047058195201334
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22037.MET minutes per week for walking,45884,-0.000386665683755918,0.00251292363238261,-0.00531199600322584,0.00453866463571401,0.877712982103278
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22038.MET minutes per week for moderate activity,46648,-0.00743765276720131,0.00262280761690059,-0.0125783556963265,-0.00229694983807616,0.00457570652811865
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22039.MET minutes per week for vigorous activity,46648,-0.293427929132185,0.0324777468785895,-0.357084313014221,-0.22977154525015,1.77147274201592e-19
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22040.Summed MET minutes per week for all activity,45884,-0.0108518268524636,0.00258858643470819,-0.0159254562644917,-0.00577819744043553,2.77361818560546e-05
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X2217.Age started wearing glasses or contact lenses,45997,-0.000375060862272315,0.00300936245257877,-0.0062734112693267,0.00552328954478207,0.900816551089682
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X22501.Year ended full time education,31250,-0.0178462985148114,0.0126143252022858,-0.0425703759112916,0.0068777788816689,0.157179711264666
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X22506.Tobacco smoking,31200,-0.0288076533825052,0.11630954042089,-0.25677435260745,0.19915904584244,0.804388229393691
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49658,0.0262815236852462,0.0655819739813137,-0.102259145318129,0.154822192688621,0.688612592457342
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23098.Weight,51191,-0.0335738649100805,0.00569368114879986,-0.0447334799617283,-0.0224142498584328,3.75225110768158e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23099.Body fat percentage,51169,0.0549946919160867,0.00551265126859821,0.0441898954296342,0.0657994884025392,2.12711968462633e-23
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23100.Whole body fat mass,51136,0.0288571322565674,0.00524881776970031,0.0185694494279547,0.03914481508518,3.87925861112102e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23101.Whole body fat-free mass,51186,-0.0521540635814719,0.00485172886815523,-0.0616634521630561,-0.0426446749998876,6.73833476389887e-27
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23102.Whole body water mass,51191,-0.0512484988844858,0.00485237223481322,-0.0607591484647197,-0.0417378493042519,5.04275433587745e-26
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23104.Body mass index (BMI),51191,0.0256654821558114,0.00982264618427564,0.00641309563463115,0.0449178686769917,0.00898296566722988
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23105.Basal metabolic rate,51189,-0.0535249011727355,0.00520187794381328,-0.0637205819426095,-0.0433292204028615,8.71827647630037e-25
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23106.Impedance of whole body,51188,0.0422230567325139,0.00398901047499753,0.0344045962015188,0.0500415172635091,3.9367355855902e-26
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23107.Impedance of leg (right),51188,0.0471556144670655,0.00328517185840803,0.0407166776245858,0.0535945513095453,1.4839005143174e-46
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23108.Impedance of leg (left),51187,0.0434643437148371,0.00326329490171691,0.0370682857074719,0.0498604017222022,2.39347522735736e-40
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23109.Impedance of arm (right),51181,0.018338688227496,0.00400674402360033,0.0104854699412393,0.0261919065137526,4.73868071865992e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23110.Impedance of arm (left),51186,0.0208915476073606,0.00400048326725396,0.0130506004035428,0.0287324948111783,1.78049975472692e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23111.Leg fat percentage (right),51187,0.0892973208874705,0.00680697742992358,0.0759556451248203,0.102638996650121,3.38963901745288e-39
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23112.Leg fat mass (right),51186,0.0552058875999141,0.00708500925916871,0.0413192694519434,0.0690925057478848,6.83293119228098e-15
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23113.Leg fat-free mass (right),51186,-0.0654706502965579,0.00521800318075312,-0.075697936530834,-0.0552433640622818,5.18509954834908e-36
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23114.Leg predicted mass (right),51185,-0.0657984504251773,0.00523797813031418,-0.0760648875605931,-0.0555320132897615,4.30913292233174e-36
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23115.Leg fat percentage (left),51184,0.0867704735228642,0.00705219443288333,0.0729481724344128,0.100592774611315,1.06467179878492e-34
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23116.Leg fat mass (left),51184,0.0503181180176799,0.00737029165499859,0.0358723463738826,0.0647638896614771,8.84270875847806e-12
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23117.Leg fat-free mass (left),51182,-0.0606011746698439,0.0054166833527664,-0.0712178740412661,-0.0499844752984218,5.4056087013027e-29
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23118.Leg predicted mass (left),51181,-0.0609083179868465,0.00543644633647043,-0.0715637528063286,-0.0502528831673645,4.52528663873333e-29
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23119.Arm fat percentage (right),51181,0.0326912637802388,0.00608175723782704,0.0207710195940978,0.0446115079663798,7.70817544970433e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23120.Arm fat mass (right),51178,0.0117688237776879,0.00595572249332442,9.56076907720864e-05,0.0234420398646038,0.0481588105566772
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23121.Arm fat-free mass (right),51178,-0.0346310255441531,0.00486131622682536,-0.0441592053487308,-0.0251028457395754,1.07594138222777e-12
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23122.Arm predicted mass (right),51177,-0.0351944223283819,0.00486445440688123,-0.0447287529658691,-0.0256600916908947,4.77720083742554e-13
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23123.Arm fat percentage (left),51173,0.0397111628461742,0.00621447337155269,0.0275307950379309,0.0518915306544175,1.68438666365222e-10
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23124.Arm fat mass (left),51172,0.0155155770438427,0.00593108412497092,0.00389065215889967,0.0271405019287857,0.0089021609452933
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23125.Arm fat-free mass (left),51168,-0.0380346089543296,0.00494056519863364,-0.0477181167436515,-0.0283511011650077,1.42392991234779e-14
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23126.Arm predicted mass (left),51167,-0.0382201756393447,0.00496389622321788,-0.0479494122368518,-0.0284909390418377,1.41065756775225e-14
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23127.Trunk fat percentage,51164,0.0283181599382191,0.00395341388520325,0.0205694687232207,0.0360668511532174,8.09503080661954e-13
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23128.Trunk fat mass,51161,0.0182968010339761,0.00431363451049572,0.00984207739340444,0.0267515246745477,2.22641959961215e-05
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23129.Trunk fat-free mass,51155,-0.0433514826033216,0.00441684578784015,-0.0520085003474883,-0.0346944648591549,1.05777751796489e-22
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23130.Trunk predicted mass,51153,-0.0435705793556003,0.00440961958953377,-0.0522134337510865,-0.0349277249601141,5.51146374512285e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23400.Total Cholesterol,39585,0.0260548580545543,0.00333556995211231,0.0195171409484142,0.0325925751606945,6.01986461208172e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39585,0.0361603452844036,0.00323519767526463,0.029819357840885,0.0425013327279223,6.77800911523435e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39585,0.0382716748229231,0.00324667097871702,0.0319081997046378,0.0446351499412085,6.13599980812077e-32
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23403.VLDL Cholesterol,39585,0.0486229080739982,0.00319382749990875,0.0423630061741771,0.0548828099738194,5.74912563289517e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39585,0.0283804897070058,0.00323696611445723,0.0220360361226696,0.0347249432913419,2.00881728457263e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23405.LDL Cholesterol,39585,0.03278847959087,0.00320828067366573,0.0265002494704851,0.0390767097112548,1.92475253286536e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23406.HDL Cholesterol,39585,-0.0291379795517275,0.00366687222823973,-0.0363250491190774,-0.0219509099843776,2.05152354944235e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23407.Total Triglycerides,39585,0.0595737730411627,0.00326319388244912,0.0531779130315624,0.065969633050763,1.06347015139242e-73
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23408.Triglycerides in VLDL,39585,0.057644406697085,0.00332055603808471,0.051136116862439,0.0641526965317311,6.97736888865734e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23409.Triglycerides in LDL,39585,0.0587918455599882,0.00311238960586665,0.0526915619324896,0.0648921291874868,1.03137085262646e-78
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23410.Triglycerides in HDL,39585,0.0521135473927828,0.00307768110377071,0.0460812924293922,0.0581458023561734,9.47393413509649e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39585,0.0309341680576981,0.0033001765224238,0.0244658220737475,0.0374025140416488,7.95209720616827e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23412.Phospholipids in VLDL,39585,0.0560760509243778,0.00322151362299348,0.0497618842233105,0.062390217625445,3.12855430855127e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23413.Phospholipids in LDL,39585,0.0341637861137726,0.00321113424466747,0.0278699629942244,0.0404576092333209,2.40755704434833e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23414.Phospholipids in HDL,39585,-0.0088417136022778,0.00345112624208053,-0.0156059210367556,-0.00207750616779996,0.0104169893759168
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23415.Total Esterified Cholesterol,39585,0.0236586180037389,0.00334873537641555,0.0170950966659645,0.0302221393415134,1.67425128364874e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39585,0.0441869586787347,0.00319722200411223,0.0379204035506747,0.0504535138067946,3.43284555764882e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39585,0.0363362635152525,0.00319442337102004,0.0300751937080532,0.0425973333224518,7.29596148516687e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39585,-0.03250911999289,0.00365851992330053,-0.039679819042559,-0.025338420943221,7.01843564048422e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23419.Total Free Cholesterol,39585,0.0313226611326572,0.00330031990712618,0.0248540341146899,0.0377912881506245,2.61458839729458e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39585,0.053428375462226,0.0032083262346764,0.0471400560422603,0.0597166948821918,9.71570744820392e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23421.Free Cholesterol in LDL,39585,0.0218970625804444,0.00325143474157852,0.0155242504869505,0.0282698746739383,1.70095938489388e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23422.Free Cholesterol in HDL,39585,-0.0160076972919572,0.00363880964031819,-0.0231397641869808,-0.00887563039693354,1.09386344584642e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39585,0.0415736384997247,0.00321001876903981,0.0352820017124067,0.0478652752870427,3.62494027190717e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23424.Total Lipids in VLDL,39585,0.0573986779049405,0.00325102060077793,0.0510266775274157,0.0637706782824652,4.2757829674313e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23425.Total Lipids in LDL,39585,0.0361042147330734,0.003202943290931,0.0298264458828487,0.0423819835832982,2.33307837515449e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23426.Total Lipids in HDL,39585,-0.0130191872674869,0.00352536385109558,-0.0199289004156343,-0.0061094741193396,0.000222369556172574
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39585,0.0112892182798333,0.00332095569971812,0.00478014510838579,0.0177982914512808,0.000677044416975624
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23428.Concentration of VLDL Particles,39585,0.0527054964771147,0.00318277118721987,0.0464672649501637,0.0589437280040656,4.48682928971352e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23429.Concentration of LDL Particles,39585,0.0362660916635161,0.00321067859780125,0.0299731616118257,0.0425590217152066,1.79465343987688e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23430.Concentration of HDL Particles,39585,0.00522677980220881,0.00332304144633937,-0.00128638143261636,0.011739941037034,0.115764329804678
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39585,0.0531425465658713,0.00350036306438816,0.0462818349596705,0.0600032581720721,1.08183571154819e-51
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39585,-0.0271939680501595,0.00320087562470066,-0.0334676842745728,-0.0209202518257462,2.13999181111806e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39585,-0.0489849100053745,0.00371308722431333,-0.0562625609650286,-0.0417072590457203,1.57175625203108e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23434.Phosphoglycerides,39573,0.0275036833316835,0.00326536389401272,0.0211035700994186,0.0339037965639484,3.98851219662562e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39573,0.0591311902514771,0.0035019818928549,0.0522673057414815,0.0659950747614727,2.09861949445593e-63
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23436.Total Cholines,39573,0.0257810155448622,0.00332150925389273,0.0192708574072324,0.0322911736824919,8.8839321186648e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23437.Phosphatidylcholines,39573,0.024127025429456,0.00331380689505859,0.0176319639151412,0.0306220869437708,3.47673173282894e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23438.Sphingomyelins,39572,0.0178241324218097,0.00342775594156744,0.0111057307763375,0.0245425340672819,2.01851571104019e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23439.Apolipoprotein B,39585,0.0378558763728433,0.00322031328375363,0.0315440623366862,0.0441676904090004,9.00422228537285e-32
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23440.Apolipoprotein A1,39585,-0.00305754470217426,0.00342693034421619,-0.00977432817683799,0.00365923877248947,0.372293538334143
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39585,0.034156462634463,0.0032284527048312,0.0278286953329938,0.0404842299359322,4.52296172989625e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23442.Total Fatty Acids,39573,0.0474590822881394,0.00312281811935259,0.0413383587742083,0.0535798058020704,8.57404914790156e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23443.Degree of Unsaturation,39573,-0.0782012649724478,0.00343001336171997,-0.0849240911614189,-0.0714784387834766,3.19149546037094e-113
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39573,-0.022597475321559,0.00318994745283915,-0.0288497723291238,-0.0163451783139943,1.46032624638853e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39573,0.0338676289777384,0.00318026542948342,0.0276343087359509,0.0401009492195259,2.16113800170299e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39573,0.0230214619772404,0.00318671963429424,0.0167754914940237,0.0292674324604571,5.27245819156231e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39573,0.0599706582241946,0.00316525466111426,0.0537667590884106,0.0661745573599785,3.59287395575024e-79
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23448.Saturated Fatty Acids,39573,0.0523523085768187,0.00313530289774301,0.0462071148972424,0.058497502256395,4.66660278296987e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23449.Linoleic Acid,39573,0.0371634184815004,0.00320105115530004,0.0308893582171124,0.0434374787458885,4.92181104076435e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23450.Docosahexaenoic Acid,39573,-0.0421108666822392,0.00332191113670891,-0.0486218125101886,-0.0355999208542897,1.20345395580126e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39573,-0.0568128091108461,0.0032028034314152,-0.0630903038364199,-0.0505353143852723,1.01164237390565e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39573,-0.0469744664079865,0.00327343895132349,-0.0533904067525806,-0.0405585260633925,2.08749102272666e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39573,-0.0754582033435598,0.00337493816048103,-0.0820730821381026,-0.068843324549017,4.98837277993951e-109
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39573,0.0721604908981629,0.00345312109467647,0.065392373552597,0.0789286082437288,1.13267457881481e-95
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39573,0.0415339799359733,0.0031363110447886,0.0353868102881877,0.047681149583759,8.10161368645317e-40
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39573,-0.0187195333337964,0.00336956191967336,-0.0253238746963562,-0.0121151919712367,2.81344675808444e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39573,-0.0754382416515662,0.00333107891299479,-0.0819671563210359,-0.0689093269820964,9.16612945001768e-112
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39573,-0.0776334741753094,0.00344440408049145,-0.0843845061730726,-0.0708824421775461,9.73626493270835e-111
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39571,0.0398982477685727,0.00319238688374346,0.0336411694764355,0.0461553260607099,1.13226807296344e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23460.Alanine,39581,0.012203148189452,0.00311239049734092,0.00610286281466377,0.0183034335642402,8.86196151440317e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23461.Glutamine,39537,-0.0146535878978984,0.00307731068456907,-0.0206851168396538,-0.00862205895614308,1.93573959488972e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23462.Glycine,39566,-0.0109398358911724,0.00322965714559873,-0.0172699638965459,-0.00460970788579892,0.000707558806222844
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23463.Histidine,39567,-0.00286860099926714,0.00307573534927281,-0.00889704228384186,0.00315984028530757,0.351012286112242
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39575,0.0170949156064787,0.00327807835377969,0.0106698820330705,0.0235199491798869,1.86229386335033e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23465.Isoleucine,39583,0.0103686384142397,0.00320308181453662,0.00409059805774789,0.0166466787707314,0.00121008885516429
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23466.Leucine,39584,0.0171817465186099,0.00330183353931975,0.0107101527815432,0.0236533402556766,1.97816680020313e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23467.Valine,39575,0.0178619131713082,0.00326232972021524,0.0114677469196863,0.02425607942293,4.43715190498982e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23468.Phenylalanine,39581,0.0068961433420035,0.00310445723716525,0.000811407157159608,0.0129808795268474,0.0263402047078746
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23469.Tyrosine,39568,0.0142320130387891,0.00316289024428998,0.00803274815998074,0.0204312779175974,6.85423447517973e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23470.Glucose,39557,0.000873073131615107,0.00317029502448954,-0.00534070511638439,0.00708685137961461,0.783018897618216
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23471.Lactate,39556,0.0358775640696304,0.00310040016950752,0.0298007797373956,0.0419543484018651,7.62981191637736e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23472.Pyruvate,39533,0.00587680979572256,0.00307556720530586,-0.000151301926676916,0.011904921518122,0.0560478449598032
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23473.Citrate,39583,0.0155496638450196,0.00315229278858509,0.00937116997939283,0.0217281577106464,8.18828532406403e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39339,0.0172761990649129,0.00305142632686551,0.0112954034642565,0.0232569946655694,1.52558845792776e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23475.Acetate,39571,-0.0258236662238073,0.00310245121272895,-0.031904470600756,-0.0197428618468585,9.22592740368035e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23476.Acetoacetate,39585,0.00417037925353169,0.00305219703548841,-0.0018119269360256,0.010152685443089,0.171847660870483
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23477.Acetone,39585,-0.00830934679670216,0.00306978961200557,-0.0143261344362331,-0.00229255915717123,0.00680058245304665
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23478.Creatinine,39161,0.0105130074855054,0.00385059336389746,0.00296584449226636,0.0180601704787444,0.00633624806170527
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23479.Albumin,39584,0.00050778969197883,0.00316176449559244,-0.00568926871938236,0.00670484810334002,0.872407948601925
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23480.Glycoprotein Acetyls,39585,0.0609179159096094,0.00328533571985003,0.0544786578987034,0.0673571739205155,6.0566980029104e-76
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39585,0.0536016533097559,0.00330118641618821,0.047131327934027,0.0600719786854848,8.29219700492187e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39585,0.0517473271001385,0.00331787415310616,0.0452442937600504,0.0582503604402266,1.96518784768385e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39585,0.0553063304811027,0.00331896846923527,0.0488011522814015,0.0618115086808038,8.15307446835597e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39585,0.0575196774618902,0.003292439160503,0.0510664967073043,0.0639728582164761,1.05213459944069e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39585,0.0590399234719407,0.00330616672839653,0.0525598366842835,0.0655200102595979,1.25785456655193e-70
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39585,0.0534812037371769,0.00326692383916657,0.0470780330124104,0.0598843744619433,9.68724957649944e-60
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39585,0.0464988351338451,0.00331609201044771,0.0399992947933676,0.0529983754743226,2.11126838009665e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39585,0.0619405747918434,0.00336001242335065,0.0553549504420761,0.0685261991416106,4.27981784742948e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39585,0.0603501713993378,0.0033649955229499,0.053754780174356,0.0669455626243196,3.23533789367252e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39585,0.060146197364723,0.00334145844592367,0.0535969388107126,0.0666954559187334,1.02137062962769e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39585,0.058480646503714,0.00329472961088489,0.0520229764663796,0.0649383165410484,8.2971033272637e-70
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39585,0.0561190360794754,0.00326668705361675,0.0497163294543866,0.0625217427045643,1.50653794592028e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39585,0.0587876687478466,0.00331759752554108,0.0522851775977861,0.0652901598979072,1.39537472336715e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39585,0.0591721636284542,0.00339629988292151,0.0525154158579281,0.0658289113989804,2.38638888207846e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39585,0.0597595798278264,0.00332602839969229,0.0532405641644295,0.0662785954912233,1.82165438710645e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39585,0.0575439328143647,0.00333235416450065,0.0510125186519435,0.064075346976786,3.32599264377878e-66
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39585,0.0611409706327412,0.00334433144035307,0.0545860810096492,0.0676958602558332,6.70672219474642e-74
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39585,0.0572264286004686,0.00327332022432371,0.0508107209607941,0.0636421362401431,8.49281140093647e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39585,0.0523891171876251,0.00322358528885771,0.046070890021464,0.0587073443537862,6.54770278428031e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39585,0.060976765962755,0.00333114189324678,0.0544477278519914,0.0675058040735187,4.42925590262526e-74
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39585,0.0536463134190773,0.00335520356506416,0.0470701144315516,0.0602225124066031,4.29676383073694e-57
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39585,0.0463274387059751,0.00319211918540433,0.0400708851025827,0.0525839923093676,2.02817207571297e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39585,0.0491255591325928,0.00320252326027161,0.0428486135424605,0.0554025047227252,1.00067060076968e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39585,0.0453624902483129,0.00319197800366406,0.0391062133611313,0.0516187671354944,1.49024590348738e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39585,0.0288847861535748,0.00323282031424349,0.0225484583376576,0.035221113969492,4.52163654976557e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39585,0.0184886143446241,0.00327375268131592,0.0120720590892449,0.0249051696000033,1.65585855986589e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39585,0.0403314732832164,0.00319448667089122,0.0340702794082696,0.0465926671581632,2.29807942681889e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39585,0.0546340330116657,0.00327882434867236,0.0482075372882679,0.0610605287350635,8.29100908036556e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39585,0.0545901029537131,0.00319751155284387,0.0483229803101392,0.0608572255972871,9.0838122837627e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39585,0.0544541900695567,0.00318940381591785,0.0482029585903577,0.0607054215487556,8.9644630132808e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39585,0.0475641896339654,0.0031760066011943,0.0413392166956245,0.0537891625723062,2.33987791033526e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39585,0.0461548935654949,0.0031835332865049,0.0399151683239453,0.0523946188070445,2.51856416609221e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39585,0.0489390342127609,0.00318676652000432,0.0426929718335525,0.0551850965919694,7.69310840337037e-53
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39585,0.0404918569040441,0.00318823349518733,0.034242919253477,0.0467407945546113,8.91637877620276e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39585,0.05503295759271,0.00322442324634325,0.0487130880298773,0.0613528271555428,9.90530681181659e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39585,0.0418370359406066,0.00319995839614311,0.0355651174841661,0.0481089543970471,7.36895050508884e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39585,0.0405029940842055,0.00319073571238001,0.0342491520879406,0.0467568360804703,9.67646802375949e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39585,0.0411364984853823,0.00317080901425498,0.0349217128174426,0.0473512841533221,2.71908092882048e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39585,0.0280284370115625,0.00331842307114911,0.0215243277921103,0.0345325462310148,3.26641151453971e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39585,0.0233678997984637,0.00336432391375644,0.016773824927501,0.0299619746694263,3.91088671439298e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39585,0.0372865942115656,0.00321784077865923,0.0309796262853935,0.0435935621377377,6.37097379628735e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39585,0.0526397656481869,0.00313054718032643,0.0465038931747471,0.0587756381216267,6.72650677503339e-63
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23523.Concentration of IDL Particles,39585,0.0282859341200075,0.00329639825338751,0.021824993543368,0.034746874696647,1.02853374781066e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23524.Total Lipids in IDL,39585,0.0250153661927695,0.00337215065605787,0.0184059509068961,0.0316247814786429,1.24758679699544e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23525.Phospholipids in IDL,39585,0.0251180978268609,0.00337074706474858,0.0185114335799536,0.0317247620737681,9.6867173792551e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23526.Cholesterol in IDL,39585,0.0186960117129048,0.00339554027260626,0.0120407527785965,0.0253512706472131,3.72724804221748e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39585,0.018704150715352,0.0033901814927232,0.0120593949896145,0.0253489064410894,3.49974897935681e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23528.Free Cholesterol in IDL,39585,0.0180365944466332,0.00339608847591965,0.0113802610338307,0.0246929278594358,1.10514699879677e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23529.Triglycerides in IDL,39585,0.0514665199904679,0.00308850143811036,0.0454130571717716,0.0575199828091642,8.12598724142333e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39585,0.0303388421262495,0.00321853864219271,0.0240305063875518,0.0366471778649472,4.82845580464298e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23531.Total Lipids in Large LDL,39585,0.0316623191582079,0.00322961306386112,0.0253322775530401,0.0379923607633757,1.25949787688358e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23532.Phospholipids in Large LDL,39585,0.0307415028079318,0.00324125284620523,0.0243886472293695,0.037094358386494,2.77766730821308e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23533.Cholesterol in Large LDL,39585,0.0278400001367713,0.00323684983759443,0.0214957744550862,0.0341842258184564,8.64194496172404e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39585,0.0301897736492919,0.00321766049842699,0.023883159072375,0.0364963882262088,7.30272776328731e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39585,0.0205163418757516,0.00329359645653034,0.0140608928209521,0.026971790930551,4.80867725502927e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23536.Triglycerides in Large LDL,39585,0.0569812233445518,0.00309539050005507,0.0509142579644439,0.0630481887246598,6.87581634267942e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39585,0.0433837341740575,0.00319102810584175,0.0371293190866077,0.0496381492615073,7.33893538938249e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39585,0.0434660822690533,0.00317619011399669,0.0372407496456198,0.0496914148924868,2.1837931415045e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39585,0.0405837109875528,0.00317311878747168,0.0343643981641083,0.0468030238109973,2.86539383476079e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39585,0.0412265375026069,0.00317874704997248,0.0349961932846609,0.047456881720553,2.86585460445913e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39585,0.0458328184198174,0.00317989522001787,0.0396002237885824,0.0520654130510524,8.48010971158474e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39585,0.0261975083496265,0.00318715742967857,0.0199506797874564,0.0324443369117965,2.19773787022819e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39585,0.0607279622927286,0.00313718201366583,0.0545790855459436,0.0668768390395136,1.60555999647111e-82
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39585,0.042245285217108,0.00320533763944184,0.035962823443802,0.048527746990414,1.85990519957773e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23545.Total Lipids in Small LDL,39585,0.0392851903241327,0.00320118463630108,0.0330108684369826,0.0455595122112828,1.83922407177738e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23546.Phospholipids in Small LDL,39585,0.0304153807919173,0.00321162873785269,0.024120588465726,0.0367101731181086,3.17575499353213e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23547.Cholesterol in Small LDL,39585,0.0377483133363497,0.00319775403888069,0.0314807154201436,0.0440159112525559,5.04302669733206e-32
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39585,0.0441398971314313,0.00319401810280187,0.0378796216499396,0.050400172612923,3.47413369182213e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39585,0.0172880754280259,0.00319905496766158,0.0110179276914092,0.0235582231646426,6.60759717078163e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23550.Triglycerides in Small LDL,39585,0.0586313669080166,0.00318181851310399,0.0523950026223327,0.0648677311937004,4.91319026820032e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39585,-0.0328745166149253,0.00374580765650534,-0.0402162996216757,-0.0255327336081748,1.85963757466086e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39585,-0.045990915907353,0.00375069166143833,-0.0533422715637721,-0.0386395602509338,2.08095231928609e-34
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39585,-0.0479926350397917,0.00370722851459553,-0.055258802928399,-0.0407264671511845,3.89232968335907e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39585,-0.0498761789932961,0.00380401851043837,-0.0573320552737553,-0.0424203027128369,4.53887982501258e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39585,-0.0527176415496519,0.00384808786647386,-0.0602598937679407,-0.0451753893313631,1.78745886515672e-42
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39585,-0.036935503390488,0.00358609609093533,-0.0439642517287212,-0.0299067550522547,8.47961448847238e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39585,0.0391186738339066,0.00303784177616252,0.033164503952628,0.0450728437151851,9.39497555934818e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39585,-0.045273567511216,0.00383362935479219,-0.0527874810466087,-0.0377596539758233,4.75718567316203e-32
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23559.Total Lipids in Large HDL,39585,-0.0454347991256764,0.00377747179020986,-0.0528386438344878,-0.0380309544168651,3.54801378605444e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23560.Phospholipids in Large HDL,39585,-0.0411231580683267,0.00370151184195614,-0.0483781212785608,-0.0338681948580927,1.43551040335163e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23561.Cholesterol in Large HDL,39585,-0.055553552633759,0.00385931153686914,-0.0631178032460225,-0.0479893020214954,1.10658056361317e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39585,-0.0581060732766779,0.00386461862499557,-0.0656807257816693,-0.0505314207716866,9.69473072729752e-51
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39585,-0.0458732148811091,0.00381441998242775,-0.0533494780466674,-0.0383969517155507,3.6155106017901e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23564.Triglycerides in Large HDL,39585,0.0300458992613281,0.00306948487628388,0.0240297089038117,0.0360620896188445,1.46217505837915e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39585,-0.00583826866176936,0.0033890874482843,-0.0124808800604066,0.000804342736867872,0.0849684464104324
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39585,-0.00236943904288211,0.003334098727865,-0.0089042725494975,0.00416539446373328,0.477300204968521
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39585,0.00185814435984823,0.00327847306904701,-0.00456766285548392,0.00828395157518037,0.570877678643859
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39585,-0.0159088738406051,0.00343934119761298,-0.0226499825879266,-0.00916776509328369,3.76568359623499e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39585,-0.0177444203293344,0.00343225906255909,-0.0244716480919502,-0.0110171925667185,2.3709570370187e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39585,-0.00789486811933437,0.00344884139873561,-0.0146545972608562,-0.00113513897781257,0.0220846249609188
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39585,0.0503914958500749,0.00308904666656332,0.0443369643836108,0.056446027316539,2.45074107767336e-59
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39585,0.0302518463890089,0.00308525961739053,0.0242047375389235,0.0362989552390944,1.24062268630506e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23573.Total Lipids in Small HDL,39585,0.0356799646836581,0.00309479473433922,0.0296141670043532,0.041745762362963,1.25082390630436e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23574.Phospholipids in Small HDL,39585,0.033687260017299,0.00310014980208718,0.0276109664052081,0.0397635536293899,2.08699041734991e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23575.Cholesterol in Small HDL,39585,0.0239226774905749,0.00308478640289308,0.0178764961409045,0.0299688588402454,9.36980561309627e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39585,0.0194418540960729,0.00307536910333751,0.0134141306535314,0.0254695775386144,2.65512673725042e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39585,0.0340897962830781,0.00312778467544011,0.0279593383192155,0.0402202542469407,1.46184239082776e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23578.Triglycerides in Small HDL,39585,0.0676502351949187,0.00331618295795454,0.0611505165973278,0.0741499537925096,2.53381292264669e-91
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38832,0.0215852149451052,0.00314122609437987,0.0154284118001207,0.0277420180900898,6.5996645457187e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38832,-0.00369785696396393,0.00314152802331409,-0.00985525188965954,0.00245953796173167,0.239178838902136
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38832,0.00281229357333486,0.0031160652679864,-0.00329519435191849,0.00891978149858821,0.366798229031499
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38832,-0.01349525252605,0.00319151174292976,-0.0197506155421924,-0.00723988950990769,2.36669278909919e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38832,-0.00419407329824704,0.00308117518235026,-0.0102331766556536,0.00184503005915948,0.173473272601581
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39401,0.0237475635618,0.00304871899199879,0.0177720743374824,0.0297230527861177,7.15868415732528e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39401,-0.0345547574195957,0.00339730066661324,-0.0412134667261577,-0.0278960481130338,3.17371593690671e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39401,-0.0352697157310166,0.00338412231198359,-0.0419025954625044,-0.0286368359995287,2.38221989033253e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39401,-0.0199771427386918,0.00326076120159264,-0.0263682346938133,-0.0135860507835702,9.19828642710158e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39401,0.0214084620540345,0.00330312147825413,0.0149343439566564,0.0278825801514126,9.36853729286067e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39581,0.0565733405090311,0.00329013826653177,0.0501246695066288,0.0630220115114334,1.15668783095987e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39581,-0.00358493117037428,0.00319834151228748,-0.00985368053445775,0.00268381819370918,0.262359509340122
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39581,-0.0177203176563744,0.00333006735026214,-0.0242472496628882,-0.0111933856498606,1.04436258885372e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39581,0.0287236450758175,0.00311386924113387,0.0226204613631951,0.0348268287884398,3.20609774379346e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39581,-0.0200685756435051,0.00307205453825149,-0.026089802538478,-0.0140473487485322,6.66123547905978e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39585,-0.00441602355683315,0.00335678896807479,-0.0109953299342597,0.00216328282059344,0.188344321921204
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39585,-0.0324291089956831,0.00348310282801231,-0.0392559905385872,-0.025602227452779,1.43830292076765e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39585,-0.0367846550681435,0.00349194869664416,-0.043628874513566,-0.0299404356227209,7.33273989629188e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39585,-0.0182266332920381,0.00342506719752513,-0.0249397649991873,-0.0115135015848888,1.04303434307182e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39585,0.0265851804841802,0.00346575408957753,0.0197923024686083,0.0333780584997522,1.80879454219394e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39585,-0.0276828067916452,0.00332360223282966,-0.0341970671679914,-0.0211685464152991,8.80667456678127e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39585,-0.0131479691620752,0.00322755615677753,-0.0194739792293592,-0.00682195909479127,4.65068091086576e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39585,-0.00185932157420404,0.00314536213174988,-0.0080242313524338,0.00430558820402572,0.554441037839272
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39585,-0.0276606677655194,0.00334904872617921,-0.0342248032688307,-0.0210965322622082,1.58137963043488e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39585,0.0177568813865686,0.00325782281197702,0.0113715486750936,0.0241422140980435,5.09743152017683e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39585,0.0139494156547054,0.00325246880836095,0.00757457679031793,0.0203242545190928,1.80655960886494e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39585,-0.0335039229493467,0.00341637045842908,-0.0402000090478677,-0.0268078368508257,1.22132139129485e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39585,-0.0361790164327875,0.00345350481603453,-0.0429478858722152,-0.0294101469933598,1.35162000752252e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39585,-0.00833204681424837,0.00312283208461217,-0.0144527977000882,-0.00221129592840852,0.00763584117349858
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39585,0.0340096202328301,0.00338422422169741,0.0273765407583032,0.0406426997073571,1.08906480875856e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39585,-0.00590219582764825,0.00313993147065113,-0.0120564615101245,0.000252069854827974,0.0601645550162008
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39585,-0.023367911178569,0.00327805872797883,-0.0297929062854075,-0.0169429160717305,1.05817717356977e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39585,-0.0193842299018298,0.00323644116867483,-0.0257276545924325,-0.0130408052112271,2.15250747215763e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39585,-0.0180683291358248,0.00321138359544627,-0.0243626409828995,-0.0117740172887501,1.8721348548969e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39585,0.0321949207236496,0.00330703865041452,0.0257131249688371,0.038676716478462,2.46576339359572e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39585,-0.0125870953227665,0.00313453671893687,-0.0187307872918828,-0.00644340335365024,5.95660978466973e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39585,-0.0254861021203476,0.00328525623319961,-0.0319252043374189,-0.0190469999032764,9.17545031101241e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39585,0.0027689721500073,0.00310142916809594,-0.00330982901946075,0.00884777331947535,0.371975152878964
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39585,-0.0401614595813612,0.00346250987895242,-0.0469479789441079,-0.0333749402186144,5.5775304815744e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39585,0.0290595308244144,0.00320856995185737,0.022770733718774,0.0353483279300549,1.49765438806723e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39585,-0.0321337763184007,0.00309758900608916,-0.0382050507703354,-0.0260625018664659,3.93243189142318e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39585,-0.00414578685322782,0.00324261306441913,-0.0105013084594893,0.00220973475303367,0.201080530025052
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39585,0.0404965676440446,0.00320348426220562,0.0342177384901216,0.0467753967979676,1.87720826518226e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39585,-0.051225288125638,0.00334669682456578,-0.0577848139017869,-0.0446657623494891,1.6608643924425e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39585,0.0229434695649485,0.00314002579325061,0.0167890190101773,0.0290979201197197,2.86762449311615e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39585,-0.0480831014779897,0.00315901598983765,-0.0542747728180715,-0.0418914301379079,6.02521491817062e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39585,0.0122547770721494,0.00312980199296151,0.00612036516594485,0.018389188978354,9.05932965239514e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39585,0.0480001766261499,0.00316223614961203,0.0418021937729103,0.0541981594793894,1.12869449004121e-51
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39585,-0.0417348947078559,0.00319064003694798,-0.047988549180274,-0.0354812402354379,6.80040770748894e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39585,0.0372333879667286,0.00321325475051362,0.0309354086557219,0.0435313672777352,6.37248476388317e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39580,-0.0475473505780575,0.00352218409190402,-0.0544508313981894,-0.0406438697579256,2.67822947387383e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39580,0.00926027914109392,0.00324506707858715,0.0028999476670631,0.0156206106151247,0.00432768567632325
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39580,-0.0133316581878477,0.00309011724174858,-0.0193882879816749,-0.00727502839402046,1.6109496394378e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39580,0.0424841443142501,0.00372001493338675,0.0351929150448121,0.0497753735836882,4.34471867745237e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39580,0.0700770938820451,0.00341683215933464,0.0633801028497492,0.076774084914341,2.85580617824204e-92
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39585,0.0347595498345023,0.00346747257901982,0.0279633035796235,0.0415557960893811,1.40077939503355e-23
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39585,-0.0612539455435234,0.0035139290766114,-0.0681412465336818,-0.054366644553365,2.03746835753439e-67
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39585,-0.058356171380623,0.00339252526398724,-0.065005520898038,-0.051706821863208,1.03443601820314e-65
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39585,-0.0248020205069002,0.00348724084497668,-0.0316370125630545,-0.0179670284507459,1.19112008043559e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39585,0.0636751379182207,0.00331577481607111,0.0571762192787213,0.0701740565577201,2.93092180694536e-81
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39585,0.0365329017400152,0.00349127808009099,0.0296899967030369,0.0433758067769935,1.53264023073271e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39585,-0.0537084003308251,0.00340515450090785,-0.0603825031526045,-0.0470342975090457,1.28016623763656e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39585,-0.0514938398001903,0.00325400689738026,-0.0578716933190556,-0.0451159862813249,5.67768975515731e-56
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39585,-0.0243586038414158,0.00369986080474903,-0.0316103310187239,-0.0171068766641077,4.73560654959806e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39585,0.0595336952299674,0.00330256284322746,0.0530606720572416,0.0660067184026933,6.38569835276653e-72
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39585,-0.00758435385069019,0.00312287719528184,-0.0137051931534426,-0.00146351454793778,0.0151665810469991
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39585,-0.0292297161995874,0.00309527210542505,-0.0352964495262205,-0.0231629828729543,4.10692309679076e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39585,-0.0273818229651257,0.00303982102296751,-0.033339872170142,-0.0214237737601094,2.34136703594237e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39585,-0.00120082723494858,0.00338436260361231,-0.00783417793802869,0.00543252346813154,0.722731926248971
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39585,0.0604163397029897,0.00338462998313838,0.0537824649360385,0.0670502144699409,1.43007904125755e-70
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51212,-0.00292407357096757,0.00265286547763355,-0.00812368990712932,0.00227554276519418,0.270370464552272
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51212,-0.00176921456027652,0.00259338779514175,-0.00685225463875435,0.0033138255182013,0.495116953590251
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49293,-0.00126930848838998,0.00248744415987273,-0.00614469904174052,0.00360608206496057,0.60985538086014
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49293,-0.0042412791537352,0.00268629642743671,-0.00950642015151116,0.00102386184404076,0.114381191746827
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49293,-0.00224358430318859,0.00267281477316639,-0.00748230125859472,0.00299513265221754,0.40124782429809
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49293,-0.00228410802178537,0.00246662115631425,-0.0071186854881613,0.00255046944459056,0.354451220701349
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24009.Traffic intensity on the nearest road,51212,0.000708115373879719,0.0641594963634954,-0.125044497498571,0.126460728246331,0.991194168886563
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24010.Inverse distance to the nearest road,51212,0.000445229343472389,0.00231881258849527,-0.00409964332997834,0.00499010201692312,0.847737777770968
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51212,0.0035534256168717,0.00234407354127599,-0.00104095852402924,0.00814780975777265,0.129551391559847
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24012.Inverse distance to the nearest major road,51212,-0.00376408393028593,0.00236840312557941,-0.00840615405642157,0.000877986195849713,0.112006061843824
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24013.Total traffic load on major roads,51212,-0.0198479442857128,0.0444306791963584,-0.106932075510575,0.0672361869391496,0.655082868508576
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51212,-0.0338593095297468,0.0431097548865502,-0.118354429107385,0.0506358100478916,0.432213538450392
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51212,-0.00331456665840973,0.00265925299308932,-0.00852670252486479,0.00189756920804532,0.21261808242513
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51212,-0.00427267111144124,0.00265818939429288,-0.00948272232425528,0.000937380101372807,0.107986647886595
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51212,-0.00350797462218346,0.00263226937971312,-0.00866722260642117,0.00165127336205426,0.182647708038226
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51165,-0.00148252750484218,0.00255343025850103,-0.0064872508115042,0.00352219580181984,0.561513307061632
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51212,-0.00170286592831414,0.00232576413339869,-0.00626136362977557,0.00285563177314729,0.464068146570366
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24021.Average evening sound level of noise pollution,51212,-0.00170121111609239,0.00232515193221571,-0.00625850890323518,0.00285608667105039,0.464384891580694
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51212,-0.00169981579875034,0.00232576601979881,-0.00625831719755601,0.00285868560005532,0.464869237973251
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51212,-0.00168227914014364,0.00232543826498225,-0.00624013813950884,0.00287557985922157,0.469425276715463
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51212,-0.00168807280271634,0.00232545944223726,-0.00624597330950138,0.00286982770406869,0.467900542000541
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2405.Number of children fathered,36056,-0.064355279077918,0.0472580321901892,-0.156981022170689,0.0282704640148529,0.1732909020203
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48106,0.00366314370192692,0.00275441760482414,-0.0017355148035284,0.00906180220738224,0.183558500285469
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48106,0.000744365911343372,0.00251563560314261,-0.00418627987081614,0.00567501169350289,0.767312222429861
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24502.Water percentage, buffer 1000m",48106,-0.00475630263952405,0.0024585069124179,-0.00957497618786314,6.23709088150362e-05,0.0530472636320862
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48106,0.00275015676841258,0.0026029407406833,-0.00235160708332669,0.00785192062015185,0.290724076278206
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48106,-0.000181944218285408,0.00254404163900178,-0.00516826583072889,0.00480437739415808,0.942986261753589
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24505.Water percentage, buffer 300m",48106,-0.00366337683098303,0.00246514315884209,-0.00849505742231352,0.00116830376034747,0.137273443780472
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51312,0.00148378351986625,0.00261721651615425,-0.00364596085179608,0.00661352789152859,0.570765088598829
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51312,0.00166857802607548,0.00247116827149352,-0.00317491178605182,0.00651206783820278,0.499542772065198
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24508.Distance (Euclidean) to coast,51312,-0.00323541374627998,0.00236350254661932,-0.00786787873765385,0.00139705124509388,0.171039737526456
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28594,0.0600663079858871,0.074615723943863,-0.0861805109440844,0.206313126915858,0.420855079049239
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2704.Years since last cervical smear test,35446,0.0686190709108812,0.0457880742138337,-0.0211255545482328,0.158363696369995,0.133998651583468
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2714.Age when periods started (menarche),38747,0.00113874690327364,0.0407083303944523,-0.0786495806698529,0.0809270744764002,0.977683810219722
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2734.Number of live births,39217,0.0178843914172814,0.0387547478299428,-0.0580749143294066,0.0938436971639693,0.644463575359678
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2744.Birth weight of first child,35395,-0.189638519524781,0.0441545465659677,-0.276181430794078,-0.103095608255484,1.76218548395533e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2754.Age at first live birth,33411,-0.00603505441960385,0.00387852587861638,-0.013636965141692,0.00156685630248425,0.119737043525744
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2764.Age at last live birth,33389,-0.00496023726542536,0.00389367936052907,-0.0125918488120623,0.00267137428121162,0.202722721906928
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2794.Age started oral contraceptive pill,36961,-7.12732562182736e-05,0.00383499186841966,-0.00758785731832081,0.00744531080588427,0.985172466103261
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2804.Age when last used oral contraceptive pill,35791,-0.00695704305942264,0.0034084385285254,-0.0136375825753324,-0.000276503543512862,0.0412605358184689
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2867.Age started smoking in former smokers,29230,-0.00232907319661839,0.00521719369675508,-0.0125547728422584,0.00789662644902157,0.655310008451315
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36310,0.00936999812016439,0.0527900774302392,-0.0940985536431044,0.112838549883433,0.859122133221831
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36306,0.158438421161532,0.0587801398344211,0.0432293470860669,0.273647495236998,0.0070389913162681
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36327,0.0671961280393826,0.059997372390665,-0.0503987218463209,0.184790977925086,0.262741939821784
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36298,0.0819194943852957,0.0585647474626371,-0.0328674106414731,0.196706399412064,0.161902382859189
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28739.Difficulty with standing for long periods,36337,0.160048775205555,0.0547870684270101,0.0526661210886152,0.267431429322495,0.00349212933330591
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36362,0.122808279468297,0.0611729426878097,0.00290931180019027,0.242707247136404,0.0447116803478686
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28741.Difficulty learning a new task,36268,0.145554183646066,0.0691285550067862,0.010062215832765,0.281046151459367,0.0352628092569768
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28742.Difficulty with joining in community activities,35835,0.018452870012444,0.0663483744584408,-0.1115899439261,0.148495683950988,0.780924350867395
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36278,0.0801017985120684,0.0568450957896991,-0.0313145892357418,0.191518186259879,0.158823500493048
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36359,0.0690558216868605,0.0772366297841698,-0.0823279726901123,0.220439616063833,0.371295645590656
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29080,0.0182343400657765,0.0707782492401616,-0.12049102844494,0.156959708576493,0.796705469915137
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2897.Age stopped smoking,29234,0.0112554523180567,0.0063049037563054,-0.00110215904430189,0.0236130636804153,0.074286854769702
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35014,0.00164965250233666,0.00741003968143024,-0.0128740252732666,0.0161733302779399,0.823832250167308
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35014,0.00475237754126346,0.00795444257208057,-0.0108383299000145,0.0203430849825414,0.550219458277542
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35014,0.0216312412556284,0.0268877944801431,-0.031068835925452,0.0743313184367088,0.421125188397612
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35014,0.00343081537306166,0.0261123023910992,-0.0477492973134927,0.054610928059616,0.895471593179858
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35014,0.0279433866143582,0.0282348766745178,-0.0273969716676967,0.0832837448964131,0.322353859548685
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35014,-0.0136170666117877,0.0240357014758913,-0.0607270415045347,0.0334929082809593,0.57104153268295
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35014,-0.0143330339436447,0.0109950645563829,-0.0358833604741553,0.00721729258686581,0.192401007567844
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35014,-0.0503787419430168,0.0202875801135982,-0.0901423989656692,-0.0106150849203644,0.0130342560497495
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34942,0.198435907223759,0.0602864183449364,0.0802745272676832,0.316597287179834,0.000999476755531478
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29003.Recent feelings of depression,34938,0.16849658663517,0.0585417201493076,0.0537548151425268,0.283238358127813,0.00400677372296822
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34949,0.0981078787766045,0.0479473994395319,0.00413097587512198,0.192084781678087,0.0407645229585523
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29005.Recent feelings of tiredness or low energy,34954,0.144810852263997,0.048704029945845,0.049350953570141,0.240270750957853,0.00295266318212824
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29006.Recent poor appetite or overeating,34957,0.205935713531223,0.0638774220007308,0.0807359664097903,0.331135460652655,0.00126814387267799
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29007.Recent feelings of inadequacy,34922,0.128127771746821,0.0625623861169853,0.00550549495752946,0.250750048536112,0.0405835542452499
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29008.Recent trouble concentrating on things,34954,0.049107189993846,0.0619609755208133,-0.0723363220269481,0.17055070201464,0.428056822872777
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34946,0.269819866775665,0.110093073691844,0.05403744233965,0.48560229121168,0.0142678980768973
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29010.Recent thoughts of suicide or self-harm,34882,0.279184633775674,0.120006685773949,0.0439715296587332,0.514397737892614,0.0200147809693357
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#0.Substances taken for depression_None of options listed,32598,-0.0307456730419568,0.0142338050849916,-0.0586439310085402,-0.00284741507537331,0.0307962189691314
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32598,-0.0251575346561781,0.0250881176747488,-0.0743302452986856,0.0240151759863295,0.31600109736019
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32598,-0.0383514010832233,0.0139012297395173,-0.0655978113726773,-0.0111049907937694,0.00581259382238097
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32598,-0.0358187616384933,0.0392942276222393,-0.112835447778082,0.0411979245010958,0.362029346333736
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32598,-0.0714561508366048,0.0237575776874973,-0.118021003104099,-0.0248912985691102,0.00263964478786422
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32598,-0.050201416491534,0.0256199335013701,-0.100416486154219,1.36531711512761e-05,0.0500898564706199
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32598,-0.00834436173026749,0.0290082299696313,-0.0652004924707449,0.0485117690102099,0.77361767858164
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32598,-0.0510219414493324,0.0361803517010861,-0.121935430783461,0.0198915478847963,0.158512889379505
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32598,-0.0501443814109705,0.0282553038902556,-0.105524777035871,0.00523601421393051,0.0759840350139107
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32598,-0.0265255820894708,0.0143669280470546,-0.0546847610616978,0.00163359688275611,0.0648832347711379
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32598,0.000367130743345417,0.020861601447821,-0.0405216080943837,0.0412558695810746,0.985959637319022
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32598,-0.0646112971688942,0.0329933953265185,-0.129278352008871,5.5757671081999e-05,0.0502254132786342
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32598,-0.0915537841719567,0.0405737867773154,-0.171078406255495,-0.0120291620884185,0.0240654309831783
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32598,-0.00245043464777431,0.0249930148342181,-0.0514367437228419,0.0465358744272932,0.921898983935122
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32598,-0.084802898521256,0.0422740366693629,-0.167660010393207,-0.00194578664930481,0.0448840327011791
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32598,-0.06168045000812,0.0403615016202685,-0.140788993183846,0.0174280931676063,0.126499065036071
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32598,-0.0440302824158838,0.0218573537191741,-0.0868706957054651,-0.00118986912630253,0.0439941560143097
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32598,0.00290882874810275,0.021546173095152,-0.0393216705183952,0.0451393280146007,0.892611483849976
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32598,-0.0661288293610831,0.0305975659991856,-0.126100058719487,-0.00615760000267947,0.0307035131783407
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29058.Recent feelings or nervousness or anxiety,34784,0.140118600335839,0.0563681095328871,0.0296371056513801,0.250600095020298,0.0129417016896478
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29059.Recent inability to stop or control worrying,34790,0.151673268011669,0.0590738586609433,0.0358885050362201,0.267458030987118,0.0102560892514745
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29060.Recent worrying too much about different things,34783,0.136174060105255,0.0540353063579491,0.0302648596436751,0.242083260566836,0.0117464828163719
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29061.Recent trouble relaxing,34788,0.130279281011091,0.0567268912844276,0.0190945740936127,0.241463987928569,0.0216601225957613
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29062.Recent restlessness,34791,0.211907099474628,0.0796216451182589,0.0558486750428407,0.367965523906416,0.00779242651510031
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29063.Recent easy annoyance or irritability,34776,0.170212753433747,0.0573700023200684,0.0577675488864132,0.282657957981081,0.00301442007792832
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29064.Recent feelings of foreboding,34767,0.159503492231734,0.065927357775907,0.0302858709909559,0.288721113472511,0.0155631363130009
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32598,-0.0313641789669632,0.0142805940791053,-0.0593541433620096,-0.00337421457191684,0.0280981088807051
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32598,-0.0217211325135045,0.0234535369413101,-0.0676900649184723,0.0242477998914632,0.35440160217249
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32598,-0.0137568718188716,0.0305613150193414,-0.0736570492567808,0.0461433056190376,0.6526206284529
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32598,-0.0889827120544526,0.0345523911715612,-0.156705398750712,-0.0212600253581928,0.0100316590889226
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32598,-0.00129885461948123,0.0214489253303927,-0.0433387482670508,0.0407410390280884,0.951714442420712
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32598,-0.0205212030214279,0.0231858068864119,-0.0659653845187952,0.0249229784759394,0.376139954771098
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32598,-0.0316319984817437,0.0231487740741741,-0.0770035956671249,0.0137395987036375,0.171828098681229
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32598,-0.0174072776345515,0.0208828879004535,-0.0583377379194404,0.0235231826503373,0.404548044357285
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32598,-0.0289993549678544,0.0282499902632416,-0.084369335883808,0.0263706259480991,0.304672038985136
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29076.Felt loved as a child,34739,-0.0816125786951813,0.0504036895173385,-0.180403810149165,0.0171786527588022,0.105437821529159
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29077.Physically abused by family as a child,34745,0.09776880204347,0.0646599842364915,-0.0289647670600534,0.224502371146993,0.130551468604044
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29078.Felt hated by family member as a child,34731,0.101017478866955,0.0659048224166654,-0.0281559730697087,0.23019093080362,0.125359606905314
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29079.Sexually molested as a child,34652,0.0611089984328057,0.0898774630737948,-0.115050829191832,0.237268826057444,0.4965731309759
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29080.Someone to take to doctor when needed as a child,34726,-0.16881245481612,0.0752352709325279,-0.316273585843875,-0.0213513237883655,0.0248657154140826
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34733,-0.201080007624926,0.0890887184156705,-0.37569389571964,-0.0264661195302114,0.024023090211333
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34675,0.0328873314497506,0.0710029869509486,-0.106278522974109,0.17205318587361,0.643242976391513
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34739,0.0766561352537708,0.0791511497540383,-0.0784801182641442,0.231792388771686,0.332827308306538
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34704,-0.108492827689307,0.110772226021311,-0.325606390691075,0.108620735312462,0.327393039375229
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34703,-0.0342096249235189,0.107851287554357,-0.245598148530059,0.177178898683021,0.751103610156275
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29086.Experienced a violent or sexual assault,34738,0.00688379034238961,0.0872978820123372,-0.164220058401791,0.177987639086571,0.937150173743418
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29087.Experienced a life-threatening injury or illness,34746,0.114954451570405,0.0609532249512021,-0.00451386933395093,0.234422772474761,0.0593289198033562
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29088.Experienced a marital separation or divorce,34746,0.0341436046486629,0.0544060545474201,-0.0724922622642805,0.140779471561606,0.530298867025019
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29089.Experienced the death of a spouse or partner,34759,-0.149081777864776,0.0870301978852936,-0.319660965719951,0.0214974099903994,0.0867429931808301
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34744,0.0176721450026322,0.0673401806761979,-0.114314609122716,0.14965889912798,0.79299421072811
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29091.Frequency of drinking alcohol,34751,-0.0882899406346293,0.0458023639402665,-0.178062573957552,0.00148269268829314,0.0539273361499898
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33659,-0.136658129527323,0.0510619825119055,-0.236739615250658,-0.0365766438039886,0.00745597467370554
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33672,-0.101930071699405,0.0511355404249949,-0.202155730932395,-0.00170441246641514,0.046252834818606
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29104.Ever used cannabis,34738,-0.12121606990403,0.0608166380753811,-0.240416680531777,-0.00201545927628276,0.0462710694901672
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29108.Ever thought that life not worth living,34692,0.104487876314316,0.0556403744695511,-0.00456725764600374,0.213543010274637,0.0604196831931253
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29109.Ever contemplated self-harm,34711,0.00801422525553337,0.071987089383618,-0.133080469936358,0.149108920447425,0.911357798912777
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29111.Ever self-harmed,34728,0.000939926974245303,0.113791578014508,-0.222091565934191,0.223971419882682,0.993409640214628
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34734,-0.0509274609055476,0.077683242607166,-0.203186616415593,0.101331694604498,0.512109256107065
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33239,-0.0271836137902152,0.0297362048813445,-0.0854665753576503,0.03109934777722,0.36065690186912
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33239,-0.0378243153505165,0.0231237139285167,-0.0831467946504093,0.0074981639493762,0.101928189132331
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33239,-0.0631623065126915,0.0241644624020507,-0.110524652820711,-0.0157999602046721,0.00896710792959777
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33239,-0.0281999689503653,0.0323054967704689,-0.0915187426204843,0.0351188047197537,0.382731482999896
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34727,-0.157043707839635,0.0512425657605307,-0.257479136730276,-0.0566082789489952,0.00218413821361583
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X29153.Pain or discomfort today,34742,0.0794169461932034,0.0489639609264601,-0.0165524172226584,0.175386309609065,0.104843689067756
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29154.Anxiety or depression today,34742,0.0557373099002354,0.0600651224210153,-0.0619903300449547,0.173464949845425,0.353455133502991
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29166.Frequency of confiding in someone close,34511,-0.0991058028113583,0.0478129186423518,-0.192819123350368,-0.00539248227234886,0.0382164860327252
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34708,0.0149953822537654,0.00765448647281922,-7.41123296028184e-06,0.0299981757404911,0.0501346432061807
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34708,-0.0262390212592598,0.00761070197520982,-0.0411559971306711,-0.0113220453878486,0.00056763651842859
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34708,0.00166128009821997,0.00946321682850083,-0.0168866248856416,0.0202091850820816,0.860649734782274
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34708,0.00524639878187672,0.0113122557250819,-0.0169256224392838,0.0274184200030373,0.642814627289584
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34708,-0.00463348284773741,0.0175165498589201,-0.0389659205712208,0.029698954875746,0.791384057613884
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34708,0.00198516552657088,0.00824182400337783,-0.0141688095200497,0.0181391405731914,0.809664434231933
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34706,0.00622398303806401,0.00903565725934983,-0.0114859051902617,0.0239338712663897,0.490948384032556
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34706,-0.0211016003559407,0.0128394495666099,-0.0462669215064961,0.00406372079461471,0.100309073895833
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34706,0.00318348538267977,0.0204306519188178,-0.0368605923782031,0.0432275631435626,0.87617853060867
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34706,0.0204060171919274,0.0203456250100184,-0.0194714078277086,0.0602834422115634,0.31589852545241
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34706,-0.0286757559141198,0.0267637282998725,-0.0811326633818699,0.0237811515536303,0.283995024931192
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34706,0.00448524207150342,0.0135502111484361,-0.0220731717794313,0.0310436559224381,0.740644069099567
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29171.Frequency of feeling 'in tune' with people,34525,-0.0304419233539985,0.058165498962315,-0.144446301320136,0.0835624546121389,0.600729511800633
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29172.Freuency of feeling that lacks companionship,34660,0.0593600926616757,0.053562915686341,-0.0456232220835525,0.164343407406904,0.267786674487404
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29173.Frequency of feeling left out,34616,0.0806230931672708,0.0547795302459775,-0.0267447861148452,0.187990972449387,0.141111152331348
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29174.Frequency of feeling isolated from others,34646,-0.0212462465331376,0.0566764714424397,-0.132332130560319,0.0898396374940443,0.707765340055915
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29175.Tendency to bounce back quickly after hard times,34725,-0.0506129730093214,0.0475001704567889,-0.143713307104628,0.0424873610859848,0.286658733163993
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29176.Ability to make it through stressful events,34725,0.154732794009455,0.0466236971600415,0.0633503475757739,0.246115240443137,0.000907159944335414
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29177.Quick recovery from stressful events,34725,-0.0633240247048775,0.0472044281108284,-0.155844703802101,0.0291966543923461,0.179791134048635
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29178.Hard to snap back when something bad happens,34725,0.108900868508272,0.0469456188198707,0.0168874556213251,0.200914281395218,0.0203742690043048
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29179.Comes through difficult times with little trouble,34725,-0.0830954114787142,0.0472204494860662,-0.175647492471404,0.00945666951397564,0.0784811323568999
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29180.Tendency to take a long time to get over setbacks,34725,0.0978306932939349,0.0472259007302063,0.00526792786273057,0.190393458725139,0.0383312178034823
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29181.General happiness,34658,0.0495613479684144,0.0486595044080684,-0.0458112806713996,0.144933976608228,0.308447193759964
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29182.Belief that own life is meaningful,34553,-0.0762226692828423,0.0484757727203881,-0.171235183814803,0.0187898452491184,0.115890448349608
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28780,0.00986327166162957,0.0688413038426987,-0.12506568387006,0.144792227193319,0.886078479416848
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2946.Father's age,33881,0.00357630043295973,0.00567991152293006,-0.00755632615198318,0.0147089270179026,0.528944392779885
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2966.Age high blood pressure diagnosed,28952,0.0037188758797772,0.00928317610072587,-0.0144761492776455,0.0219139010371999,0.68872863383896
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50735,0.029000393327237,0.00243210165119828,0.0242334740908884,0.0337673125635857,1.07308021255496e-32
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50735,0.043605267751778,0.00286918545463403,0.0379816642606953,0.0492288712428607,6.01678306358502e-52
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30020.Haemoglobin concentration,50735,0.0423057605684944,0.003061379480853,0.0363054567860225,0.0483060643509663,2.7467734027293e-43
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30030.Haematocrit percentage,50735,0.0415547825245383,0.0029969913202994,0.0356806795367514,0.0474288855123251,1.44850546793697e-43
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30040.Mean corpuscular volume,50735,-0.0101720553368487,0.00243661123665974,-0.0149478133607018,-0.00539629731299564,2.99353367436544e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50734,-0.00999871838422202,0.00244160256671034,-0.0147842594149743,-0.00521317735346976,4.23137007412326e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50734,-0.00346416645193749,0.00237959436478094,-0.00812817140690814,0.00119983850303315,0.145465061788363
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50735,0.00836108803493309,0.0023250708413984,0.00380394918579224,0.0129182268840739,0.000323655455021225
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30080.Platelet count,50735,0.0335305691204758,0.00245094140984132,0.0287267239571868,0.0383344142837648,1.83803607425833e-42
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30090.Platelet crit,50735,0.0328973636170226,0.00251179086531863,0.027974253520998,0.0378204737130471,4.50245253879339e-39
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50735,-0.0121812631266111,0.00236838084099869,-0.0168232895749685,-0.00753923667825366,2.71866015401484e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30110.Platelet distribution width,50735,0.00701292060206435,0.00234328152990733,0.00242008880344599,0.0116057524006827,0.00276702204523499
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30120.Lymphocyte count,50697,0.0104326315366472,0.0024846978127799,0.00556262382359857,0.0153026392496958,2.69253812935468e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30130.Monocyte count,50697,0.0182886606127712,0.00246916144083135,0.0134491041887417,0.0231282170368006,1.33161262257264e-13
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30140.Neutrophill count,50697,0.0277152571635455,0.00240900876232179,0.0229935999893947,0.0324369143376962,1.4711427138924e-30
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30150.Eosinophill count,50697,0.00843428741909126,0.00237029781062832,0.00378850371025974,0.0130800711279228,0.000373872562058294
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30160.Basophill count,50697,0.0547068400898563,0.0323659302080489,-0.00873038311791954,0.118144063297632,0.0909898207995124
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30170.Nucleated red blood cell count,50697,0.375576588786183,0.13926739208069,0.102612500308031,0.648540677264335,0.00700525712089159
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30180.Lymphocyte percentage,50697,-0.0151293888712956,0.00243584582428904,-0.0199036466869021,-0.0103551310556891,5.33718214582672e-10
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30190.Monocyte percentage,50697,-0.00306956972287863,0.00243939226357202,-0.0078507785594798,0.00171163911372253,0.208282011342394
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30200.Neutrophill percentage,50697,0.0132795774002955,0.00239986824106237,0.00857583564781322,0.0179833191527777,3.16903072874256e-08
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30210.Eosinophill percentage,50697,-0.00094234998405877,0.00234023063431192,-0.00552920202731014,0.0036445020591926,0.687191285280427
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30220.Basophill percentage,50697,-0.000436537554129259,0.00233080983773576,-0.00500492483609136,0.00413184972783284,0.851434618528733
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50696,0.373449153826763,0.139399711689942,0.100225718914476,0.64667258873905,0.00738916376037083
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30240.Reticulocyte percentage,50260,0.031212362646234,0.002494347581625,0.026323441386249,0.036101283906219,7.98731551335138e-36
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30250.Reticulocyte count,50260,0.0390298216545903,0.00255440321394095,0.0340231913552661,0.0440364519539146,1.75931466338269e-52
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30260.Mean reticulocyte volume,50260,-0.00403326054965718,0.00242210029411503,-0.00878057712612263,0.000714056026808276,0.0958864442863889
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30270.Mean sphered cell volume,50260,-0.012287528824545,0.00243481317909765,-0.0170597626555764,-0.00751529499351361,4.52725063427864e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50260,0.0184675153428751,0.00252066758579878,0.0135270068747094,0.0234080238110407,2.43123232426061e-13
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50260,0.0323628502078111,0.0025504411369125,0.0273639855794626,0.0373617148361596,8.70304114042306e-37
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50260,0.0389451348890126,0.0025909266197241,0.0338669187143534,0.0440233510636719,7.43105582252431e-51
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30500.Microalbumin in urine,31914,0.0162161164463033,0.00451136355077639,0.00737384388678152,0.025058389005825,0.000326952074453754
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50859,0.0110518294488365,0.00248313953102193,0.00618487596803354,0.0159187829296395,8.59137996331537e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30520.Potassium in urine,50796,0.00831516737260534,0.00230250844909887,0.00380225081237156,0.0128280839328391,0.000305158685240748
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30530.Sodium in urine,50803,0.0145285766744201,0.00239178580106099,0.00984067650434059,0.0192164768444997,1.26146747389383e-09
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30600.Albumin,48114,0.00619962422291295,0.00259076703627124,0.00112172083182132,0.0112775276140046,0.0167202281037316
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30610.Alkaline phosphatase,50347,0.0226627072223211,0.00243906708750875,0.017882135730804,0.0274432787138382,1.63383424591986e-20
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30620.Alanine aminotransferase,50338,0.0530693153467761,0.00256146694591161,0.0480488401327894,0.0580897905607629,1.33434848343952e-94
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30630.Apolipoprotein A,47983,-0.0127686103765393,0.00282410680167384,-0.0183038597078201,-0.00723336104525863,6.17557488221783e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30640.Apolipoprotein B,50190,0.0417919215562556,0.00246982019385081,0.036951073976308,0.0466327691362032,6.8555632790192e-64
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30650.Aspartate aminotransferase,50262,0.0330228788460939,0.00241860909067638,0.0282824050283682,0.0377633526638196,2.67310433529515e-42
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30660.Direct bilirubin,46224,-0.00757794839380596,0.00267174700137978,-0.0128145725165103,-0.00234132427110159,0.00456766725542843
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30670.Urea,50337,-0.00842553777146613,0.00254192602567044,-0.0134077127817802,-0.00344336276115207,0.000918885286733272
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30680.Calcium,48111,0.0196383656171132,0.00251647288469603,0.014706078763109,0.0245706524711174,6.24235096425976e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30690.Cholesterol,50352,0.0328219388413727,0.0025424506209431,0.0278387356243242,0.0378051420584211,5.17699532280554e-38
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30700.Creatinine,50341,-0.0122132393588711,0.00307898909557321,-0.0182480579861946,-0.00617842073154765,7.30849080660593e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30710.C-reactive protein,50270,0.0520433451976791,0.00263128761307498,0.0468860214760521,0.057200668919306,1.92225922334131e-86
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30720.Cystatin C,50347,0.0477968239231809,0.00282784619682606,0.0422542453774019,0.05333940246896,9.36278485259775e-64
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50337,0.0596000171355921,0.00260433414414873,0.0544955222130606,0.0647045120581237,8.54159760583949e-115
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30740.Glucose,48078,0.00720849607414117,0.00256309373748022,0.00218483234867994,0.0122321597996024,0.00492098086971723
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50112,0.0217351781212333,0.00256174820124334,0.0167141516467963,0.0267562045956702,2.27877875818446e-17
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30760.HDL cholesterol,48093,-0.0352953405607554,0.0029836237228491,-0.0411432430575397,-0.0294474380639712,3.36240405638577e-32
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30770.IGF-1,50229,-0.025672152713554,0.00250584979356825,-0.0305836183089478,-0.0207606871181603,1.38739818236831e-24
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30780.LDL direct,50296,0.036758321576047,0.00251483577501988,0.031829243457008,0.041687399695086,3.39572959282079e-48
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30790.Lipoprotein A,45069,-0.00678323377630611,0.00265290840799931,-0.0119829342559848,-0.00158353329662745,0.0105677147821688
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30810.Phosphate,48049,0.00299601874889412,0.00251941866613039,-0.00194204183672145,0.00793407933450969,0.23438419210155
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30830.SHBG,47867,-0.0187453886932111,0.00292350351757628,-0.0244754555876606,-0.0130153217987616,1.46332233185295e-10
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30840.Total bilirubin,50250,-0.00434278825248095,0.00247297850287381,-0.00918982611811362,0.000504249613151721,0.07908357554921
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30850.Testosterone,48225,0.000280272225056652,0.00416977824382022,-0.00789249313283098,0.00845303758294429,0.946410984560715
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30860.Total protein,48094,0.0212274997304906,0.00255620651583852,0.0162173349594471,0.0262376645015341,1.05599829635182e-16
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30870.Triglycerides,50328,0.0571722377602591,0.00251592918736313,0.0522410165530274,0.0621034589674909,3.14090938510058e-113
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30880.Urate,50317,0.0383479396324685,0.00304959106821607,0.032370741138765,0.044325138126172,3.68803199789255e-36
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30890.Vitamin D,49277,-0.0203670648610315,0.00263901931759249,-0.0255395427235128,-0.0151945869985502,1.22824116338055e-14
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3137.Number of measurements made,49399,0.0314478949038325,0.037185229009793,-0.0414351539553619,0.104330943763027,0.397722843752089
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3143.Ankle spacing width,39626,0.00100613416456131,0.00429562703756936,-0.00741329482907462,0.00942556315819725,0.814814989535994
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39625,-0.00951032395057051,0.00329523670946678,-0.0159689879011254,-0.00305166000001562,0.00390599681053583
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3146.Speed of sound through heel,39626,-0.00935675124620391,0.00320115849652111,-0.0156310218993853,-0.00308248059302253,0.00347251044705955
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39626,-0.00984070063933236,0.00323308886041111,-0.0161775548057381,-0.00350384647292659,0.00234037387390803
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3148.Heel bone mineral density (BMD),39617,-0.0098807722081329,0.00323615848309212,-0.0162236428349935,-0.00353790158127235,0.00226761371188115
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3526.Mother's age at death,35109,5.26600364104375e-05,0.00435434694479546,-0.00848185997538866,0.00858718004820953,0.990351096839288
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3581.Age at menopause (last menstrual period),30252,-0.0051489230457695,0.00600915981647725,-0.0169268762860649,0.0066290301945259,0.391562254916166
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30232,-0.00739339740576407,0.00546330110322609,-0.0181014675680872,0.00331467275655906,0.176012957641089
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4100.Ankle spacing width (left),32619,-0.0128601467747401,0.00576118734757532,-0.0241520739759877,-0.00156821957349247,0.0256266522283445
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32618,-0.00689984024171777,0.00446202645001364,-0.0156454120837445,0.00184573160030896,0.122056970845042
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4103.Speed of sound through heel (left),32619,-0.00811720428560116,0.00434867943890755,-0.01664061598586,0.000406207414657645,0.0619921652967885
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32619,-0.00801815463432365,0.00439018495595536,-0.0166229171479961,0.000586607879348855,0.0678267673761926
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32612,-0.0075645030744074,0.00439759258524209,-0.0161837845414819,0.00105477839266709,0.085441182813148
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32619,-0.00802318063409325,0.0043902387298512,-0.0166280485446016,0.000581687276415109,0.0676579683497106
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4119.Ankle spacing width (right),32607,-0.0112891159070891,0.00563449607215063,-0.0223327282085044,-0.000245503605673917,0.0451467652031399
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32607,-0.00118244078428511,0.00448228620477392,-0.00996772174564201,0.00760284017707178,0.791937896518453
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4122.Speed of sound through heel (right),32607,-0.00331358440425218,0.00436003646942901,-0.011859255884333,0.00523208707582869,0.447281005742914
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32607,-0.00270091304661048,0.00440517925852949,-0.0113350643933283,0.00593323830010732,0.539811506277001
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32598,-0.00274195486565789,0.00441931624000808,-0.0114038146960737,0.00591990496475795,0.534979217586724
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32607,-0.00270746391447817,0.00440519123600847,-0.0113416387370548,0.00592671090809843,0.538829895389997
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4194.Pulse rate,32902,0.0381091839018137,0.00419290429820031,0.0298910914773411,0.0463272763262864,1.21152011115516e-19
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4195.Pulse wave reflection index,32902,-0.00204877446490152,0.00413017093033961,-0.0101439094883672,0.00604636055856411,0.619870649409427
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4196.Pulse wave peak to peak time,32897,-0.0296431123007489,0.00444039036508731,-0.03834627741632,-0.0209399471851778,2.60380434585371e-11
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4198.Position of the pulse wave peak,32902,0.0210184444530188,0.00424873179699529,0.012690930130908,0.0293459587751295,7.67270588704765e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4199.Position of pulse wave notch,32902,0.013934506378384,0.00417223472240253,0.00575692632247508,0.022112086434293,0.000841723865022517
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32902,0.0278439364554622,0.00434629789809455,0.0193251925751969,0.0363626803357275,1.56471087003974e-10
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4269.Number of triplets attempted (left),32771,-0.158837285501209,0.171059482815214,-0.494113871819028,0.17643930081661,0.353147526189835
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4270.Volume level set by participant (left),32685,-0.0120418508005013,0.0505437672671664,-0.111107634644147,0.0870239330431447,0.811695828017975
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4276.Number of triplets attempted (right),32778,-0.170016140993767,0.167480286504867,-0.498277502543307,0.158245220555773,0.310066099007723
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4277.Volume level set by participant (right),32678,-0.013245426409711,0.0501016833404715,-0.111444725757035,0.0849538729376132,0.791500323929312
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4288.Time to answer,32936,-0.00930845408255073,0.00478156215873307,-0.0186803159136675,6.34077485660856e-05,0.0515968291579362
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4290.Duration screen displayed,32936,-0.00142736638371428,0.00425551464412891,-0.00976817508620695,0.00691344231877839,0.737319285704487
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X46.Hand grip strength (left),51550,-0.0158686694541933,0.00331397560825602,-0.0223640616463751,-0.00937327726201149,1.68977251778133e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X47.Hand grip strength (right),51529,-0.017173087043428,0.00328369050425182,-0.0236091204317615,-0.0107370536550944,1.70914904397211e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X48.Waist circumference,51604,0.052892396216387,0.00518247879842202,0.0427347377714798,0.0630500546612941,2.0586090870109e-24
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X4803.Tinnitus,32728,-0.00609828544905403,0.0625266147537191,-0.128650450366344,0.116453879468235,0.922306894253178
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4825.Noisy workplace,32859,0.210573762216438,0.0685212212765543,0.0762721685143919,0.344875355918485,0.00212468714067202
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4836.Loud music exposure frequency,32799,0.0494623588194273,0.0737446886276865,-0.0950772308908382,0.194001948529693,0.502413476310842
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X49.Hip circumference,51601,-0.0326633654706499,0.00410016017092131,-0.0406996794056557,-0.0246270515356441,1.69635218010057e-15
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X50.Standing height,51578,-0.0225830007671013,0.00325126672553241,-0.0289554835491449,-0.0162105179850578,3.84332388252612e-12
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X5057.Number of older siblings,32078,0.0224234497001016,0.0531366162002288,-0.0817243180523469,0.12657121745255,0.673038836941988
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X51.Seated height,51442,-0.0147141053964975,0.00301633949652395,-0.0206261308096844,-0.00880207998331052,1.07691133007807e-06
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5181.Ever had eye surgery,29991,-0.0226266612777617,0.132559077911746,-0.282442453984784,0.237189131429261,0.864472257289872
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29976,-0.0012197392217293,0.00519575700472327,-0.0114034229509869,0.00896394450752831,0.814405367986823
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29974,-0.00377366713052097,0.00515191378483498,-0.0138714181487975,0.00632408388775558,0.463904514804346
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5190.Duration at which refractometer first shown (right),29923,-0.00602202616092627,0.00509485482219803,-0.0160079416124344,0.00396388929058187,0.237259239288592
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5193.Duration at which refractometer first shown (left),29921,-0.00620695469711076,0.0051065207553941,-0.0162157353776832,0.00380182598346167,0.224224379819965
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5199.logMAR, initial (right)",29953,-0.00466233849711373,0.0631500996407023,-0.12843653379289,0.119111856798663,0.941148499871197
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5200.Final number of letters displayed (right),29953,0.166901932953393,0.479467575468505,-0.772854514964876,1.10665838087166,0.727778257216613
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5201.logMAR, final (right)",29899,0.00665236903472274,0.00493779597324597,-0.00302571107283937,0.0163304491422848,0.177955270240463
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5202.Number of rounds to result (right),29953,-0.0662697280283655,0.0598881762296616,-0.183650553438502,0.0511110973817713,0.26852892953461
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5206.logMAR, initial (left)",29949,0.0112304802858065,0.0620654807704628,-0.110417862024301,0.132878822595914,0.856416240593405
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5207.Final number of letters displayed (left),29949,-0.409916539441231,0.412783519314113,-1.21897223729689,0.39913915841443,0.320722859636735
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5208.logMAR, final (left)",29899,0.00402100996756984,0.00493699072902573,-0.00565549186132059,0.0136975117964603,0.415410287886482
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5209.Number of rounds to result (left),29945,-0.0246546482053254,0.0596568880296366,-0.141582148743413,0.0922728523327624,0.679420374127184
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29713,0.017679721658041,0.00514747617069264,0.00759066836348345,0.0277687749525986,0.000597462991403369
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29713,0.018801329246492,0.00506718699193915,0.0088696427422913,0.0287330157506928,0.000208844777316912
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5256.Corneal hysteresis (right),29713,-0.00319164304322994,0.00516827820870777,-0.0133214683322972,0.00693818224583729,0.536899502489669
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5257.Corneal resistance factor (right),29713,0.00810049810603612,0.00508403603849536,-0.00186421252941478,0.018065208741487,0.111142339562105
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29696,0.0132999946355444,0.00518750290956858,0.00313248893278997,0.0234675003382988,0.0103765575064739
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29696,0.0167504369514454,0.00507445968572287,0.00680449596742855,0.0266963779354622,0.000969436602414453
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5264.Corneal hysteresis (left),29696,0.00373828277992178,0.005153104445877,-0.00636180193399714,0.0138383674938407,0.468209480398862
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5265.Corneal resistance factor (left),29696,0.0125798765761659,0.0050601923673831,0.00266189953609498,0.0224978536162367,0.0129448542402283
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29813,0.449941531435722,0.25494113266836,-0.0497430885942625,0.949626151465707,0.0776345355530156
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51506,0.000104563822660517,0.0141918934318319,-0.02771154730373,0.0279206749490511,0.994121408054144
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51506,-0.0338054400073365,0.0159728131343111,-0.0651121537505862,-0.00249872626408675,0.0343166365291335
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51506,0.0124744046776621,0.037551552756727,-0.0611266387255227,0.086075448080847,0.739745208865432
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51506,-0.0214065356833342,0.0065361078934632,-0.0342173071545221,-0.00859576421214636,0.00105747107721469
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51506,0.0139006201952854,0.00585949206625652,0.00241601574542264,0.0253852246451482,0.0176833326137064
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37607,0.000199701780456202,0.00662409620998652,-0.0127835267911174,0.0131829303520298,0.975949634524569
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37607,-0.00812960507187567,0.0236854882353667,-0.0545531620131945,0.0382939518694431,0.731429575972664
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37607,-0.00255135723126901,0.0113290066926464,-0.0247562103488559,0.0196534958863179,0.821822578935657
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37607,0.00758286853350665,0.00715635019229931,-0.00644357784339999,0.0216093149104133,0.289345238595311
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51590,0.0269754024436236,0.0132958705987361,0.000915496070100753,0.0530353088171464,0.0424825278963663
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51590,0.0269754024436236,0.0132958705987361,0.000915496070100753,0.0530353088171464,0.0424825278963663
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51590,0.00880028742666469,0.00971776854303739,-0.0102465389176886,0.027847113771018,0.365162220498152
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51590,-0.00251301027693389,0.0151919355809096,-0.0322892040155167,0.0272631834616489,0.868616675724753
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51590,0.0468861242188414,0.0370607690023645,-0.025752983025793,0.119525231463476,0.205840839502725
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51590,0.0283258395086151,0.026177870626232,-0.0229827869187996,0.0796344659360299,0.279238454438767
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51590,0.0306838979633436,0.0385470616832696,-0.0448683429358647,0.106236138862552,0.426032262256438
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51505,-0.00262572054944811,0.00743705272391127,-0.0172023438883142,0.011950902789418,0.724046684296194
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51505,-0.00103511412010248,0.0128194515800841,-0.0261612392170673,0.0240910109768623,0.935644867883078
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51505,0.0132512478417122,0.00625038372381663,0.00100049574303165,0.0255019999403928,0.0340090683624597
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51505,0.0346646695560537,0.0117948824536906,0.0115466999468201,0.0577826391652873,0.00329589422661619
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51505,0.0110563763443847,0.0101907762833729,-0.00891754517102612,0.0310302978597955,0.277957885947305
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51505,0.0398288457070727,0.00832278999243768,0.0235161773218949,0.0561415140922506,1.71428669169668e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29974,-0.0422280359871528,0.022159301638483,-0.0856602671985795,0.00120419522427388,0.0567415326226697
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29974,-0.0689928918762078,0.0191961645056665,-0.106617374307314,-0.0313684094451014,0.000328080972623361
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29974,0.0344771324382366,0.0239946384786794,-0.012552358979975,0.0815066238564483,0.150806622960747
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29974,0.0172516079052544,0.019890622826069,-0.0217340128338408,0.0562372286443495,0.385798731571468
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51458,-0.00876544570560862,0.0206219195511472,-0.0491844080258572,0.0316535166146399,0.670800047348686
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51458,0.0636238008070805,0.0298412615627989,0.00513492814399467,0.122112673470166,0.033009504614586
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51458,0.0594061128686213,0.0614035043923876,-0.0609447557404583,0.179756981477701,0.333317084699539
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51458,-0.00450954706707933,0.0531761782724045,-0.108734856480992,0.0997157623468334,0.932417911641585
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51458,0.0169067008713642,0.0191114147483205,-0.0205516720353439,0.0543650737780723,0.376359127449073
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51458,0.0136795998727173,0.0245904213341485,-0.0345176259422137,0.0618768256876483,0.578011729327451
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51458,-0.00327924170928768,0.0100136869662403,-0.0229060681631186,0.0163475847445432,0.743310409783969
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33417,0.00382524855157361,0.0190906803868291,-0.0335924850066115,0.0412429821097587,0.841193479709434
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33417,0.0346290703749748,0.0212245247288188,-0.00697099809350996,0.0762291388434596,0.10280530945973
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33417,-0.025464022611142,0.0276365198730841,-0.079631601562387,0.0287035563401029,0.356869925009061
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33417,0.00392165465012663,0.00815272683581137,-0.0120576899480636,0.0199009992483169,0.630510682170587
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35551,-0.0117874901639191,0.00905434297507014,-0.0295340023950565,0.00595902206721842,0.192989776879763
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35551,-0.00745884707932588,0.00732488814479441,-0.0218156278431229,0.00689793368447116,0.308562091661958
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35551,-0.00348470482828203,0.00724798991367271,-0.0176907650590805,0.0107213554025165,0.630680270579758
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35552,-0.00780131922590873,0.0176284589563751,-0.0423530987804039,0.0267504603285865,0.658105816193506
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35552,0.0294931162739691,0.0115033617366381,0.00694652727015854,0.0520397052777797,0.0103636354906052
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35552,-0.033652174776112,0.0144496864273417,-0.0619735601737017,-0.00533078937852222,0.0198802156924926
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51505,-0.0276540206446336,0.017269922006438,-0.061503067777252,0.00619502648798484,0.109325830715893
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51505,-0.0169403774350261,0.0112759604692834,-0.0390412599548216,0.00516050508476945,0.133019578200331
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51505,-0.0249201825677012,0.0337897679185183,-0.091148127687997,0.0413077625525946,0.4608204877615
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51505,0.00713245488287511,0.012790358734138,-0.0179366482360353,0.0322015580017855,0.577092656485718
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51505,-0.0267944947819591,0.0139693279907529,-0.0541743776438347,0.000585388079916545,0.0551092866577249
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51505,-0.0129510975125546,0.0155416577656055,-0.0434127467331414,0.0175105517080322,0.404674262966583
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51505,0.0193551597872867,0.00500162254542546,0.00955197959825285,0.0291583399763206,0.000109185305792619
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28008,0.017414507241243,0.0172782326538286,-0.0164508287602611,0.0512798432427471,0.313567469820648
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28008,0.0215965791190647,0.0220225636764992,-0.0215676456868738,0.0647608039250032,0.326819154527087
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28008,-0.0237490273399638,0.0160819129611408,-0.0552695767437998,0.00777152206387223,0.139817535559615
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28008,0.0118789483973185,0.0133399196203504,-0.0142672940585682,0.0380251908532052,0.373259172373756
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51639,0.0150518041962206,0.00535937369210376,0.0045474317596972,0.0255561766327439,0.00498075212354366
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51639,0.00644372668187595,0.0158133414588314,-0.0245504225774336,0.0374378759411855,0.68365368409051
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51639,0.00362354997048579,0.00540735961334488,-0.00697487487167017,0.0142219748126418,0.502790385881936
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51639,0.0118727989299514,0.00525892902488631,0.00156529804117421,0.0221802998187285,0.0239754816390992
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51639,0.0367912157047484,0.00759292660403944,0.0219090795608311,0.0516733518486657,1.26999850767094e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51639,-0.00918099501864263,0.00783020700805359,-0.0245282007544277,0.00616621071714241,0.241002465604475
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51639,0.00912072973894905,0.00579541358827752,-0.00223828089407489,0.020479740371973,0.115548760134376
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51639,0.0451029979666204,0.0164417083953391,0.0128772495117558,0.0773287464214849,0.00608814536748071
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42650,-0.0361527982920538,0.0057201527389274,-0.0473642976603515,-0.0249412989237561,2.6701528617986e-10
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42650,0.0179009023101498,0.0060138026958092,0.00611384902636374,0.0296879555939358,0.00291800971336791
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42650,0.0206527109545583,0.00720203091782386,0.00653673035562356,0.0347686915534931,0.00414027817218709
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42651,-0.0112863214060971,0.00989235314173331,-0.0306753335638944,0.00810269075170021,0.253920370105888
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42651,-0.010771848834476,0.00634881058862604,-0.023215517588183,0.00167181991923108,0.0897752608019224
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51403,-2.91572849998925e-05,0.00593890771636656,-0.0116694164090783,0.0116111018390786,0.996082807811473
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51403,-0.0088627392196241,0.00465642574913209,-0.017989333687923,0.000263855248674796,0.0570072295904532
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51403,0.00970199037519631,0.0055602597017975,-0.00119611864032679,0.0206000993907194,0.0810167735869783
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51403,-0.045025232576629,0.00864470350707772,-0.0619688514505014,-0.0280816137027567,1.91825760634347e-07
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51419,-0.0168990208574829,0.00511026892226244,-0.0269151479451173,-0.00688289376984849,0.000944635860302776
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51419,-0.0495897598250103,0.00700757339217639,-0.063324603673676,-0.0358549159763446,1.51270781612813e-12
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51505,-0.0316361186982739,0.00539377657082285,-0.0422079207770867,-0.0210643166194611,4.53419305404266e-09
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51505,-0.0296743382024834,0.00664250744749454,-0.0426936527995727,-0.0166550236053941,7.95120689610475e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51505,-0.00271934793468348,0.00995096643728215,-0.0222232421517565,0.0167845462823895,0.784644059483735
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51505,-0.0484977869714128,0.0115919302552983,-0.0712179702717973,-0.0257776036710282,2.87618587113957e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51505,-0.00650875018243038,0.0114694652555736,-0.0289889020833547,0.015971401718494,0.570389282054479
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51505,-0.0616857442137231,0.0163919017413493,-0.0938138716267677,-0.0295576168006785,0.000168110114534913
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39626,-0.00983926556837071,0.00323311003409338,-0.0161761612351937,-0.00350236990154768,0.00234398213310646
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X864.Number of days or week walked 10+ minutes,51123,-0.0415545357713421,0.0287867111258623,-0.0979764895780322,0.0148674180353481,0.14888218598893
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X874.Duration of walks,47570,0.0053138821015969,0.00242690607720615,0.000557146190272835,0.010070618012921,0.0285651071011918
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50411,-0.109457662224336,0.0281449424910594,-0.164621749506813,-0.0542935749418599,0.000100874001069927
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X894.Duration of moderate activity,44416,-0.0109254536431959,0.0338893633085554,-0.0773486057279645,0.0554976984415728,0.747163626612265
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30180,-0.00748926263796554,0.00480675721534736,-0.0169105067800464,0.00193198150411528,0.119266803806486
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50403,-0.238060533055817,0.028830334286313,-0.29456798825699,-0.181553077854643,1.55870784364867e-16
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X914.Duration of vigorous activity,39526,-0.00608420382599232,0.00309273146888762,-0.0121459575050121,-2.24501469725819e-05,0.0491709765882
